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Title Site Specific Isotopic Labeling of Phenylalanine and Tyrosine: Application to Pth1

Structural insight into biological macromolecules furthers understanding of function and
provides a variety of information about cellular processes. Though NMR spectroscopy can be
utilized to provide such insight, limitations, including size, are significant barriers. Site specific
isotope labeling can be used to provide information on a variety of systems including large, slow
tumbling systems and membrane proteins that are not amenable to study by traditional means. In
effect, site specific isotope labeling increases the size barrier and thereby number of
macromolecular systems able to be studied by NMR spectroscopy. Methyl labeling has been
established as a leading method for site specific studies. However, more options are needed to
extend utility and supplement systems where methyls are sparse or inadequately located.
Aromatic amino acids are well positioned to be additional site specific probes, complementing
existing methyl labeling. Aromatics are often found at important interaction interfaces and play
significant roles in terms of structure and interactions. They have the added properties of having
distinct 13C side chain chemical shifts, multiple magnetically equivalent 1H positions in the side
chains, and reduced effective correlation times due to ring flipping. Thus, they are excellent
probes for studying large systems.
Site specific isotope labeled (SSIL) phenylalanine and tyrosine with α, γ and ε carbons
13

C labeled are produced by recombinant and inexpensive means. Reduced number of peaks per

residue and elimination of C-C scalar coupling in SSIL provides numerous advantages in
improving the NMR spectra of large protein systems. Optimized production conditions resulted
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CHAPTER 1

INTRODUCTION

Proteins play crucial roles in the normal functioning and maintenance of cells.
Virtually every cellular process involves protein activity. Interaction of proteins with a
variety of biomolecules, such as other proteins, nucleic acids, or small molecule ligands,
regulate many of these cellular processes. For example, proteins are responsible for
carrying oxygen in blood, replicating DNA during cell division, and cascades like
respiration and photosynthesis, among many others.
The function and mechanism of action of a protein, and in turn the biological
process it is involved in, can be better understood when the three-dimensional structure of
that protein is known (Clore & Gronenborn 1991). Shape and fold of a protein are
specific to the function it performs. The Y-shape of antibodies allows binding to foreign
antigens whereas the donut shape of DNA polymerase forms a ring around DNA strands.
Small changes in protein structure can have large impacts on function, which in turn can
cause disease. For example, misfolded proteins are the cause of Alzheimer’s disease and
cystic fibrosis. In sickle cell anemia, a single glutamate to valine mutation causes
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clumping of hemoglobin. This change impacts oligomerization which leads to the
disease condition.
By late 1990s, the importance of protein-protein interactions in the regulation of
most cellular activities was realized. Understanding protein interactions helped in
understanding diseases at the molecular level and aided in prevention and treatment of
the disease condition. For instance, protein-protein interaction mapping helped in
identifying that aggregation of key Huntington’s disease-causing protein Htt occurs due
to its interaction with another protein GIT1 (Goehler et al.s 2004). Therapeutic strategies
for Huntington’s disease then were directed towards GIT1. Many such examples
reinforce the need to study the structure of proteins as well as their interactions with other
biomolecules.
Principle experimental methods for determination of protein structure at high
resolution are X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy
and cryo-electron microscopy. Generally being considered complementary techniques,
these methods have their advantages and limitations. Solution NMR spectroscopy is
advantageous as it characterizes molecules in a more native environment without the
need for protein crystal formation NMR can also help in understanding the dynamic
multi-domain arrangement of proteins (Frueh et al. 2013). Although X-ray
crystallography has been used to solve the structure of many biomolecules including the
ribosome, some large systems like integral membrane proteins are especially difficult to
crystallize (Kang & Li 2011) and others like intrinsically disordered proteins do not form
highly diffracting crystals. Loose structural parts like surface loops cannot be resolved
by X-ray crystallography (Doolittle 2003) whereas these regions can be studied by NMR
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spectroscopy. Crystallized proteins are not needed for cryo-EM but only large, stable
systems like molecular machines made up of dozens of proteins can withstand electron
bombardment in cryo-EM (Callaway 2015). Solution NMR spectroscopy overcomes all
these limitations by eliminating the crystallization step and provides more accurate
functional information about the macromolecule in its native form (Frueh 2014).
However, as the size of the protein increases, difficulty in their study by NMR
spectroscopy increases due to increased relaxation, broader line widths, and greater
chemical shift overlap (spectral crowding) (Kainosho et al. 2006).
Although numerous developments in NMR experimentation, hardware, and
specific isotope labeling helped overcome this barrier to a certain extent, there is still
need for improvement. Selective isotope labeling of proteins has made a major impact in
the field by allowing the study of much larger systems. The most successful strategy for
selective isotope labeling is the 13C methyl labeling of isoleucine, leucine and valine
residues in a highly deuterated background, or ILV labeling (Gardner et al. 1997; Rosen
et al. 1996). Due to their hydrophobic nature, ILV side chains are commonly located in
the hydrophobic core of the protein providing significant insight into structure and
structural changes (Janin et al. 1988). ILV side chains also have distinct and generally
well resolved 13C chemical shifts and larger NOEs (Wang et al. 1999). However, with
this labeling strategy, information is limited by the number and location of ILV residues
in the proteins. Hence, there is a need for developing more probes that can report on
larger systems.
With their numerous NMR advantages, aromatic amino acids are excellent
candidates to be developed into site-specific probes (Lichtenecker 2014). Like methyl
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residues, aromatic amino acids are hydrophobic in nature with multiple magnetically
equivalent 1Hs and distinct side chain 13C chemical shifts (Wang et al. 1999). Aromatic
residues have also been reported to be found with high frequency at protein “hotspots”
(Bogan & Thorn 1998). Hot spots are interface regions in the proteins that participate in
binding and have a high binding energy. The research presented here focuses on the
development of new site-specific isotopically labeled (SSIL) phenylalanine and tyrosine
that can be used for NMR study of large macromolecular systems. Site-specific isotope
labeling will be applied to the study of a novel antibiotic target protein, peptidyl-tRNA
hydrolase, in complex with its natural substrate, peptidyl tRNA.

1.1 Size Barrier in NMR Spectroscopy
NMR has always been a powerful and versatile tool for structural biology. As
mentioned earlier, since the proteins are in an environment close to physiological
conditions, NMR spectroscopy is the best technique to study protein dynamics, kinetics
and thermodynamics at atomic resolution (Frueh et al. 2013). However, in this
technique, line width is dependent on rotational correlation times which sets an upper
molecular weight limit for NMR spectroscopy (Clore & Gronenborn 1991) and hence
large proteins need to be perdeuterated for NMR studies i.e. all 1H bound to carbons are
replaced with 2H in proteins. Nonetheless, their larger volume in highly concentrated
samples reduces protein to solvent ratio. Not all backbone amide protons in large
perdeuterated samples are accessible and exposed long enough to the solvent for
exchange thus undetected in the spectrum (Xu et al. 2006; Metzler et al. 1996). Large
proteins are slow tumbling with faster relaxing NMR signals which results in loss of
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sensitivity (Frueh et al. 2013). Additionally, the higher number of resonances increase
spectral crowding and overlap (Frueh 2014). Another major obstacle for studying larger
proteins by NMR spectroscopy is the scarcity of measurable structural constraints (Frueh
et al. 2013).
The size barrier is apparent in the size distribution of the NMR structures
deposited in the Protein Data Bank (PDB), the central repository of the 3D structures of
proteins and nucleic acids (Kainosho & Güntert 2009). Of the 129,367 structures
deposited up to now (May, 2017) in PDB, 115,790 were determined by X-ray
crystallography and 11,790 were NMR structures. The distribution of X-ray and NMR
structures deposited each year since 2000 is shown in the Figure 1.1 below.
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Figure 1.1: New structures deposited each year from 2000 to 2016.
Gray bars indicate X-ray structures and black bars indicate NMR structures. Data
obtained from PDB.
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The number of NMR structures is considerably lower than X-ray structures, with
the difference getting larger every year. Moreover, the number of NMR structures has
been decreasing since 2008. These differences can partly be attributed to the size
limitations for NMR spectroscopy. Figure 1.2 shows the size distribution of NMR and
X-ray structures deposited in PDB until January 2009. As the size of the protein
increases beyond 25 kDa, there are much fewer NMR structures. Thus, new techniques
need to be developed to extend the solution study of biological macromolecules to larger
systems.

Figure 1.2: Size distribution of NMR and X-ray structures by Jan, 2009.
Gray bars indicate X-ray structures and black bars indicate NMR structures (Kainosho &
Güntert 2009).
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1.2 History of Biomolecular NMR
Pioneering research in NMR for bulk materials was first reported by Bloch and
Purcell individually in 1946 and in 1952, for which they were awarded the Nobel prize in
physics (Becker 1993). Application of NMR for chemistry began in the mid-1950s.
Even in 1958, when the observation frequency was limiting at 40 MHz, 1H chemical
shifts of angular methyl groups proved to be of great value in the study of many steroid
compounds (Shoolery & Rogers 1958). Development of experiments using Nuclear
Overhauser Effects, Fourier Transform-NMR and superconducting magnets led to the
first protein NMR spectrum using high field strength superconducting magnet in 1967
(McDonald & Phillips 1967). By then, 13C experiments were already being used to
complement the existing 1H and 19F experiments. Specialized protocols for selectively
labeling nuclei in proteins in order to obtain small number of peaks in the 1D spectrum
were in use even before the development of 2D NMR experiments (Becker 1993).
However, these selectively labeled experiments were limited to useful study of ligand
binding and other dynamic conformational changes in proteins (Goto & Kay 2000).
Detailed structural studies of proteins became possible with the advent of homonuclear
2D experiments without the use of extensive heavy isotope labeling techniques. Then,
heteronuclear, multidimensional experiments along with methods to uniformly 15N, 13C
label proteins helped in overcoming the problem of 1H chemical shift overlap in
homonuclear 2D experiments (Goto & Kay 2000). Taking advantage of magnetization
transfer through bonds, correlation spectroscopy (COSY) helped in identifying spin
coupling. At the same time, Nuclear Overhauser Enhanced spectroscopy (NOESY)
allowed characterization of 1H-1H interactions through space and provided information
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about inter-nuclear distances (Wuthrich et al. 1979). Even with these advancements,
NMR spectroscopy was still limited to smaller biomolecular systems to the 1980s. By
the later part of 1990s, transverse relaxation-optimized spectroscopy (TROSY) was
developed allowing the characterization of larger systems (Pervushin et al. 1997). FTNMR methods that were used in study of whole cells helped in the advancement of
investigation into metabolic pathways (Becker 1993). These studies majorly depended
on 31P and 13C labeling. Eventually this led to the development of an imaging technique,
referred to as magnetic resonance imaging (MRI), commonly used for diagnostic
purposes. These developments in NMR complemented by isotope labeling strategies
advanced the structural studies of proteins by NMR.

1.3 Selective Isotope Labeling in Protein NMR
Large macromolecular complexes are at the forefront of structural biology. Stable
isotope labeling techniques are powerful tools for study of biological macromolecules by
NMR. In the beginning, one dimensional continuous wave experiments with 1H, 13C, 15N
or 19F at specific sites were used to study ligand binding, local conformations,
conformational changes, interactions, kinetics and dynamics of proteins (Goto & Kay
2000). Definitive tertiary structure determination of small proteins by NMR was
developed after the advent of multidimensional techniques using uniform 15N in early 80s
(Ohki & Kainosho 2008). NMR assignments using samples deuterated to various
degrees helped in structural studies of many proteins. Structures of 29 kDa methyl
transferase (Yu et al. 1997), 26 kDa Cdc42 and GTPase binding domain complex (AbdulManan et al. 1999) were solved using deuteration. However, the size barrier still
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remained around 30 kDa. Additionally, elimination of the hydrogens challenged NOE
experiments. Hence, a number of selective isotope labeling techniques have been
developed.
Popular 13C methyl labeling of isoleucine, leucine, valine (Gardner et al. 1997;
Rosen et al. 1996), alanine (Godoy-Ruiz et al. 2010), methionine (Fischer et al. 2007),
and threonine (Sinha et al. 2011) side chains all take advantage of magnetically
equivalent hydrogens and fast methyl rotation that allow for observation in slow tumbling
systems. Rosen et al. developed a method to protonate methyl groups of alanine, valine,
leucine and isoleucine residues in 13C, 15N and 2H labeled proteins (Rosen et al. 1996).
Later, an efficient and cost effective method was developed to produce proteins that
contain protonated ILV residues (Goto et al. 1996). This labeling strategy allowed for
rapid backbone assignments and sidechain methyl 1H, 13C assignments. Similarly, the
methyl containing residue peaks were assigned in the 723 residue protein, malate
synthase G (Tugarinov & Kay 2003). ILV methyl labeling allowed the study of 42 kDa
maltose binding protein (MBP) and β-cyclodextrin complex (Goto et al. 1996),
membrane protein OmpX (Hagn & Wagner 2015) and 20S core particle of the
proteasome (Figure 1.3) (Sprangers & Kay 2007).
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Figure 1.3: Structural studies of proteasome using ILV labeling.
Proteasome (left) and 670 kDa 20S core particle studied by ILV labeling (enlarged inset)
(Figure modified from (Sprangers & Kay 2007))

Commonly tucked in the hydrophobic core of proteins, these methyl groups are
favorable targets for selective protonation. While providing tremendous insight, 13C
methyl labeling can be limited by the number and location of sites probed. Stereo array
isotope labeling (SAIL) uses chemically synthesized amino acids with isolated 1H-13C
spins which are incorporated into proteins by cell free protein expression (Zhang &
Neubert 2009). Using SAIL approach, routine structure calculations by NMR have been
extended to proteins 50 kDa in size. Despite the advantages, this technique has limited
usage due to the excessive cost. To overcome these limitations and provide a more
complete picture of the system, more site-specific probes readily implemented with
methyl labeling are needed.
10

1.4 Aromatic Amino Acids in Protein NMR
The three aromatic amino acids, phenylalanine (Phe), tyrosine (Tyr) and
tryptophan (Trp) (Figure 1.4) make up 10% of proteins and have UV absorption maxima
at 260 nm (Phe) and 280 nm (Tyr and Trp). Aromatic residues are excellent probes for
reporting structure and structural changes since they are often found in protein "hot
spots" (Bogan & Thorn 1998) are also reported to be found in important binding
interfaces and have significant structural roles (Churchill et al. 2010; Duan et al. 2000;
Butterfield et al. 2002; Makwana & Mahalakshmi 2015). Additionally, identification of
unambiguous aromatic side chain NOEs can be instrumental for accurate structure
determination (McFeeters, Altieri, et al. 2007; McFeeters, Xiong, et al. 2007). Like
methyl groups, aromatic side chains have distinct 13C chemical shifts and 1H degeneracy.
In addition, distinct biosynthesis pathways make simultaneous labeling of both aromatic
and methyl containing residues possible. Thus, aromatic-aromatic, aromatic-methyl, and
methyl-methyl information can be acquired from one sample. Overall, site-specific
labeling of aromatic amino acids holds great potential to advance NMR studies of
biological macromolecules.
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Figure 1.4: Aromatic amino acids phenylalanine, tyrosine and tryptophan.

Several attempts have been made for site-specific labeling of aromatic residues.
Earliest alternate 13C incorporation in aromatic amino acids was obtained from
hydrolysates of proteins expressed using different 13C carbon sources. Phenylalanine
with only the epsilon carbon 13C labeled was produced from commercially available sitespecific labeled tyrosine and incorporated into recombinant proteins (Wang et al. 1999).
The utility of this method was demonstrated in 21 kDa Dbl homology domain. Improved
1

H-13C site-specific labeling came from synthetically prepared stereo array isotope

labeled (SAIL) aromatic amino acids (Zhang & Neubert 2009) incorporated to proteins in
a cell-free expression system. However, the cost of SAIL aromatic amino acids is
prohibitive and in spite of considerable improvements, cell-free protein production is not
always reliable and not necessarily scalable to the milligram quantities necessary for
structural biology (Casteleijn et al. 2013). Alternatively, site-specific labeling of
phenylalanine has been achieved using synthetic 13C ketoacid precursors, an excellent
approach limited by their current commercial unavailability (Lichtenecker et al. 2013;
12

Lichtenecker 2014). Herein, an efficient and inexpensive production of SSIL–Phe and
Tyr using genetically modified bacteria is reported. SSIL eliminates C – C scalar
coupling due to 13C labeling of only the alternate carbon atoms of the amino acid. C – C
scalar coupling refers to magnetization transfer between two adjacent 13C carbons that
causes signal splitting (Günther 1980). SSIL thus makes the NMR resonances of Phe and
Tyr more distinct without any signal splitting. In addition, lack of C – C coupling makes
constant time data collection unnecessary, greatly benefitting large, slow tumbling
systems. Limiting the number of NMR active atoms in the molecule reduces chemical
shift overlap and overcrowding of peaks. Reported to be found with high frequencies at
protein hotspots and binding interfaces (Bogan & Thorn 1998), these reagents will be
useful in the study of many macromolecular complexes. Additionally, bacterial
production of SSIL aromatic amino acids makes them readily scalable, economically
feasible and thus readily utilizable unlike other alternatives. However, in order to be able
to produce large amounts of these amino acids by microbial fermentation, a complete
understanding of the pathway and diverse metabolic engineering are necessary. Hence, a
detailed summary of the pathway is given below.

1.5 Biosynthetic Pathway of Phenylalanine and Tyrosine
Aromatic amino acid synthesis by biotechnological means has been in use due to
their utility in various industries. They are used in the synthesis of artificial sweetener
aspartame, and neurotransmitters like serotonin and dopamine that are used in treatment
of Parkinson’s disease. Since chemical synthesis of Phe and Tyr results in the production
of a racemic mixture of D and L amino acids, enzymatic methods are the best way to
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produce large quantities of L amino acids. Since E. coli is the microorganism used for
production of Phe and Tyr in this research, details of the pathway in E. coli are described
here.
In animals, Phe and Trp are essential amino acids whereas Tyr is synthesized
from Phe by hydroxylation. However, microorganisms and plants synthesize all three of
these amino acids. Bacterial strains auxotrophic for Phe, Tyr and Trp were observed to
survive when shikimate was the sole compound provided to them. Due to the significant
role of this compound in the pathway, it is also called shikimate pathway. Triple
auxotrophic strains were unable to survive in a medium containing chorismate, which is
the last common product of the pathway. This was presumed to be due to its inability to
enter the cells (Pittard 1996).
The shikimate pathway involves utilization of two molecules of phosphoenol
pyruvate (PEP) and one molecule of erythrose-4-phosphate (E4P) derived from
glycolysis in order to synthesize chorismate in seven steps catalyzed by 6 enzymes.
Chorismate then branches out to production of Trp or the common Phe and Tyr
production. Steps of the biosynthesis pathway with genes of our interest pointed out have
been shown in Figure 1.7. Apart from analyzing the gens at the enzymatic bottlenecks of
the pathway, transfer of 13C carbon label through the pathway was tracked to obtain 13C
labeling at specific, desired sites of Phe and Tyr.
Steps in synthesis of the precursors for the aromatic biosynthesis pathway from 213

C-glycerol are shown in Figure 1.5 (PEP) and Figure 1.6 (E4P). Condensation of the

precursors, PEP and E4P, into 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP) is
the first committed step of the pathway and is catalyzed by the enzyme DAHP synthase
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(DS). There are three isozymes of this enzyme that are coded by the genes aroF, aroG
and aroH. Each of these gene products is inhibited by one of the three aromatic amino
acids - aroF by Tyr, aroG by Phe and aroH by Trp. By making changes to the amino
acid residues 147 through 149 that are involved in allosteric regulation, feedback resistant
mutants of all three enzymes have been developed (Ray et al. 1988; Kikuchi et al. 1997;
Weaver & Herrmann 1990). The next step that results in the formation of 3dehydroquinate (DHQ) catalyzed by DHQ synthase encoded by aroB involves a cascade
of reactions involving divalent cations and NAD. It is noteworthy that in feedback
resistant DS strains, DHQ synthase becomes limiting and causes accumulation of DAHP.
Shikimate, being an important compound in the pathway is the enzymatic bottleneck.
Shikimate dehydrogenase encoded by two paralogs aroE and ydiB is responsible for the
synthesis of shikimate which is then phosphorylated to shikimate-3-phosphate by
shikimate kinase also encoded by two paralogs aroK and aroL. 5-enolpyruvylshikimate3-phosphate synthase (EPSP synthase) encoded by aroA then condenses a second PEP
molecule with S3P to form EPSP. The 3 carbons from the second PEP get incorporated
the backbone of Phe and Tyr, resulting in 13C labeling of the Cα when 2-13C-glycerol is
utilized. The 13Cγ is also derived from a PEP (first PEP that condenses with E4P) while
the 13Cε is derived from E4P when using 2-13C-glycerol. Then, EPSP is converted to
chorismate by chorismate synthase encoded by aroC. In the Phe and Tyr biosynthesis
pathway, chorismate is first converted to prephenate which then branches out to Phe and
Tyr. Chorismate mutase-prephenate dehydratase is a bifunctional enzyme encoded by
pheA and tyrA. The protein coded by pheA converts prephenate to phenylpyruvate while
that coded by tyrA converts it to 4-hydroxy phenylpyruvate. An aminotransferase
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encoded by tyrB then converts phenylpyruvate and 4-hydroxy phenylpyruvate into
phenylalanine and tyrosine respectively.

Figure 1.5: Biosynthetic route for production of phosphoenolpyruvate from 2-13Cglycerol. 13C carbons are marked in red.
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transketolase

Figure 1.6: Biosynthetic route for production of Erythrose-4-Phosphate.
Conversion of phosphoenolpyruvate that was produced from 2-13C-glycerol into E4P is
shown. 13C carbons are marked in red.
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Erythrose 4-phosphate

Phosphoenolpyruvate

aroF
aroH

aroG

3 Deoxy D-arabino-heptulosonate 7-phosphate

ydiB
Shikimate

aroL, aroK

Shikimate 3-phosphate
aroC
Chorismate

tyrA

Prephenate

4-Hydroxy phenyl pyruvate

pheA
phenyl pyruvate

tyrB

tyrB

Tyrosine

Phenylalanine

Figure 1.7: Biosynthesis pathway of phenylalanine and tyrosine.
Genes that are specific to Tyr production are shown in Red and those specific to Phe
production are shown in Blue. Fate of the 13C carbon, derived from 2-13C-glycerol,
through the pathway to Phe and Tyr is shown in the structures of intermediates.

18

Overexpressing the right combination of genes results in enhanced production of
phenylalanine or tyrosine in E. coli cells. This strategy will be used for production of
SSIL-Phe and SSIL-Tyr which will be useful in the study of large proteins by NMR
spectroscopy. Using these reagents, high resolution solution study of the Pth1:peptidyltRNA complex, a promising new antibiotic target, is possible.

1.6 Peptidyl tRNA Hydrolase
About 10% of the time, ribosome stalling during translation occurs due to various
physiological reasons resulting in accumulation of peptidyl tRNA which is toxic to cells
(Heurgue-Hamard et al. 1996). Peptidyl tRNA hydrolase (Pth) is an enzyme that
hydrolyzes the ester bond between the peptide chain and the 2’ or 3’ hydroxyl group of
the terminal ribose of the tRNA thus recycling the tRNAs (Shiloach et al. 1975).
Bacterial Pth, referred to as Pth1, is an essential enzyme (Das & Varshney 2006).
However, eukaryotic cells contain many types of Pths along with Pth1 (Richter et al.
2010; Dujeancourt et al. 2013). Hence, Pth1 is an attractive target to be developed into a
new class of antibiotics because compounds inhibiting the enzyme will lead to the death
of infecting prokaryotic cells while the eukaryotic host cells remain viable.
Since the first discovery of penicillin in 1928, which was considered to be a major
breakthrough in the field of medicine, antibiotics have helped save the lives of many.
However, extensive usage and misuse supports genetic alterations like changes in gene
expression, horizontal gene transfer across species and mutagenesis that leads to drug
resistance (Ventola 2015). By 2015, many drug resistant bacterial phenotypes emerged
making bacterial infections again a serious threat to human race and many public health
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organizations including CDC consider antibiotic resistance to be a “crisis or a nightmare
scenario that could have catastrophic consequences” (Ventola 2015). While resistant
strains of gram positive bacteria like Staphylococcus aureus and enterococcal species
pose a serious threat, gram negative bacteria are also concerning as they develop into
multi-drug resistant (MDR) strains (Levin et al. 1999). Methicillin-resistant
Staphylococcus aureus (MRSA) alone causes the death of more Americans per year than
HIV/AIDS, emphysema, Parkinson’s disease and homicide together (Golkar et al. 2014).
Despite the increase in antibiotic resistance bacterial strains, the number of new
antibiotics developed is alarmingly low due to economic and regulatory hurdles (Golkar
et al. 2014). Bacterial drug resistance occurs at a much faster pace than the process of
development and approval of new antibiotic compounds (Silver 2011). Only two new
classes of antibiotics have been developed over the past three decades both of which are
ineffective against MDR gram negative bacteria (Högberg et al. 2010). Hence, there is a
dire need for new classes of antibiotics to combat the growing issue of antibiotic
resistance.
The essential bacterial enzyme, Pth1, is a promising new antibiotic target.
Sequence conservation of Pth1 across bacterial species suggests that inhibitors against
one are likely to inhibit the Pth1 of other species as well. Thus, there is the potential for
development of broad spectrum antibiotics. Moreover, small molecule inhibitor studies
show that narrow and even species dependent inhibition may be possible (Harris et al.
2011). These findings drive towards structural studies of Pth1.
Pth1 is a monomeric, globular protein about 21 kDa in size (Emmanuelle Schmitt
et al. 1997). It was first identified in E. coli and later detected in archaea and eukaryotic
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cells as well. Until now, crystal structures of Pth from many bacterial species have been
solved along with many attempts to study the structure of the enzyme in complex with
tRNA. The structure of the enzyme by itself is well understood owing to the high
resolution crystal structures of the enzyme from various species. The E. coli Pth1
(EcPth1) structure has been solved with 1.2 Å resolution (PDBID: 2PTH) as seen in
Figure 1.7 (Emmanuelle Schmitt et al. 1997). Structures of Pth1 from M. tuberculosis
(Pulavarti et al. 2008; Selvaraj et al. 2007), P. aeruginosa (Hughes et al. 2012), F.
tularensis (Clarke et al. 2011) A. baumannii (Kaushik et al. 2013) and S. typhimurium
(Vandavasi et al. 2014) have also been reported.

Figure 1.7: Structure of EcPth1 (PDB ID: 2PTH).
Surface model (left) and ribbon model (right). His20 residue essential for catalytic
activity is shown in red, active site residues are shown in orange, Phe residues are colored
in blue while Tyr are in green.
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Pth1 typically has 191 – 194 amino acid residues (Goodall et al. 2004). In the
secondary structure, this enzyme consists of 6 α-helices and 7 β-strands which are
conserved across all species (Pulavarti et al. 2008). Active site and peptidy-tRNA
binding channel of the enzyme are well resolved. Three active site residues, N10, H20,
and D93 (numbered as in EcPth1), are highly conserved and are important for the
mechanistic action of the enzyme (E Schmitt, Mechulam, et al. 1997). Other residues
flanking the channel that aid in the binding and interaction with the substrate were
identified (Vandavasi et al. 2014). NMR resonance assignments helped in identifying a
mobile helix 4 with flanking loops that serves as a lid for the active site (Vandavasi et al.
2014).
It was observed that Pth1 binds to N-blocked aminoacyl tRNA molecules except
formyl-methionyl-tRNAfMet (E Schmitt, Fromant, et al. 1997). The earliest reports of
Pth1 interaction with tRNA molecules date to as early as 1975 when Shiloach et al.
carried out binding studies to identify the kinetic parameters and substrate specificity of
EcPth1 (Shiloach et al. 1975). Many of these studies helped in understanding that one
site in Pth1 containing conserved Arg and Lys residues binds to the 5’ phosphate of the
peptidyl tRNA and another site containing a cluster of Asn residues helps in binding to
the 3’ end (Sharma et al. 2014). Ito et al. reported that Pth1 binds 3 regions of the tRNA
molecule namely CCA site, acceptor site, and TΨC site (Ito et al. 2012). Although
numerous reports of the protein interacting with aminoacyl tRNAs are available, there
has not been any progress in the attempt to study the enzyme in complex with its natural
substrate peptidyl tRNA. Overall shape of the complex was obtained by small angle
neutron scattering (SANS) but high resolution structure was unachievable due to
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heterogeneity of the substrate molecule (Hames et al. 2013). In spite of being a low
resolution structure, the shape of the complex in this study suggests a different interaction
between Pth1 and TΨC loop contradictory to what was proposed earlier (Hames et al.
2013). Hence, the need to produce a homogenous substrate molecule i.e. peptidyl tRNA
with a specific peptide.

1.7 Overview of the Research
The objectives of this research are to develop new SSIL phenylalanine and SSIL
tyrosine reagents and then apply them to the study of the Pth1:peptidyl-tRNA complex.
SSIL phenylalanine and tyrosine are 13C labeled at α, γ and ε positions, as shown in
Figure 1.8. To inexpensively achieve this isotope labeling pattern, these amino acids
were produced by bacteria grown in media containing 2-13C-glycerol as the sole carbon
source. Yields were optimized with an alternative bacterial production system found to
be more efficient for the production of tyrosine.
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B)

A)

Figure 1.8: A) SSIL phenylalanine (left) and B) SSIL tyrosine (right).
13
C carbon atoms marked with an asterisk (*).

In addition to production of SSIL Phe and Tyr, a methodology for high level SSIL
amino acid incorporation into recombinant expressed bacterial proteins is also presented.
Compatibility of this method with ILV-methyl labeling is also demonstrated. Since this
general protocol is applicable to any recombinant protein, it increases the applicability of
SSIL reagents. The current laboratory scale cost of producing SSIL for protein
production is on the order of uniform 13C labeling, making it economically feasible for
more widespread utilization. Current efforts focus on deuteration of background
positions and conversion to ketoacid precursors for more efficient incorporation to
recombinant systems.
The final aspect of the proposed research focusses on gaining high resolution
understanding of bacterial Pth1 and its complex with substrate peptidyl-tRNA. Pth1s are
of interest due to their potential to be developed as new antibiotic targets with new
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classes of small molecule antibiotics. A high resolution structure of this protein in
complex with its natural substrate will be valuable in understanding the catalytic
mechanism of this enzyme as well as aid in the search and optimization of small
molecule inhibitors as part of drug discovery and development. The major limiting factor
for obtaining the structure of the complex is the lack of homogeneous substrate,
milligram quantities of specific peptide peptidyl-tRNA. Hence, initial studies aimed at
synthesizing milligram quantities of specific peptide peptidyl-tRNA were reported. The
methods were designed for compatibility with SSIL aromatic amino acids which can then
be readily incorporated into the peptide attached to the tRNA, allowing for the complex
to be studied by NMR spectroscopy.
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CHAPTER 2

SITE SPECIFIC ISOTOPE LABELED PHENYLALANINE

2.1 Background
Described in this chapter are an inexpensive means for SSIL phenylalanine
biosynthesis and a general methodology that results in high level incorporation of
phenylalanine into recombinant proteins expressed in bacteria. Phenylalanine with
isolated 1H-13C spin systems at the Cα and Cε positions, termed SSIL-Phe (Figure 1.8A),
was produced using genetically modified bacteria grown in media containing 2-13Cglycerol as the sole carbon source. Alternate carbon labeling eliminates C ‒ C scalar
coupling improving the quality of the NMR spectra of large macromolecular systems.
This labeling strategy is an attractive technique for structural studies of protein systems
previously not within the limitations of NMR spectroscopy.
The strains used for production of phenylalanine were JB161 E. coli cells
obtained from Barker et al. (Barker & Frost 2001). These are modified D2704 strains
with a 2.274 plasmid and enhanced carbon flux to the aromatic biosynthesis pathways.
Originally, the cells obtained had aroA, aroL, aroB and aroC inserted as a cassette in the
genome and aroF, tktA and ubiC in the plasmid. For production of phenylalanine, the
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original ubiC gene (directing carbon flux to production of p-hydroxybenzoic acid) in
p2.274 was replaced with genes in the phenylalanine biosynthesis pathway (Hames
2014). These genes were cloned from E. coli K12 and placed under control of separate
promoters. The gene combinations for greatest yield of phenylalanine were identified
and used for production of SSIL-Phe.
Production yield efficiency as high as 300 mg of phenylalanine produced per
gram of carbon source provided was achieved, in line with other industrially oriented
systems producing phenylalanine from glycerol (Thongchuang et al. 2012). To make
scale-up and purification straightforward, the system was engineered to secrete
phenylalanine into the growth media. The phenylalanine production from this cell line
was then compared to another phenylalanine producing cell strain ATCC 31884. In
addition to production, methodology is also presented for high level phenylalanine
incorporation without isotope scrambling into recombinant bacterial proteins that is
compatible with ILV-methyl labeling. Incorporation experiments were conducted using
Ubiquitin and E. coli Pth1. Ubiquitin is a small 8.6 kDa protein with a robust and
efficient expression method and well-resolved NMR assignments. Hence, this protein
was chosen as a model protein for incorporation of SSIL-Phe. However, to test the
ability of incorporation into other proteins, the protocol was also tested on E. coli Pth1.
The current laboratory scale cost of producing SSIL-Phe for protein production is on the
order of uniform 13C labeling, making it economically feasible for more widespread
utilization.
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2.2 Methods
The methods used for optimizing conditions, production and purification of SSILPhe, and its incorporation into recombinant proteins are described below.

2.2.1 Production of SSIL-Phe
JB161 cells that were transformed with the modified 2.274 plasmid (Figure 2.1)
were grown to an OD600 of 0.8 at 37 °C in LB media supplemented with 30 g/mL
kanamycin and 25 g/mL chloramphenicol. Cells were then pelleted by centrifugation
and resuspended in an equal volume of M9 minimal media (composition in Table 2.1)
containing the appropriate carbon source and 15 g/mL kanamycin, and 25 g/mL
chloramphenicol. Cultures were grown at 30 °C for a defined period of time, the media
containing secreted phenylalanine clarified by centrifugation. Phenylalanine producing
E. coli strain, ATCC 31884 cells, were also tested for phenylalanine production by
comparing yield obtained when grown with conditions similar to that of JB161 cells.
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Figure 2.1: A vector map of modified p2.274 showing where the phenylalanine
biosynthesis genes were inserted (Ramaraju et al. 2017). Genes included and restriction
sites are shown.

Table 2.1: M9 minimal media composition
Component

g/L

Sodium Phosphate Dibasic

6.7

Potassium Phosphate Monobasic

3

Sodium Chloride

0.5

Ammonium Chloride

1

Carbon Source

According to the
testing condition

Divalent ions, vitamins, and trace elements
according to (T. Maniatis 1982)
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2.2.2 Optimization of Production Conditions
The parameters that were optimized for maximizing production yield efficiency
were carbon source, concentration of carbon source, temperature, and length of
fermentation time. The JB161 E. coli cells, genetically modified to harbor overexpressed
genes of the aromatic amino acid biosynthesis pathway, were analyzed for their ability to
produce phenylalanine. The gene combination that lead to highest phenylalanine
production was identified and other conditions for phenylalanine production using the
strain were optimized. The different carbon sources tested were glucose, glycerol and
acetate and their concentrations were varied between 0.5 g/L and 8 g/L. The different
temperatures tested were 25 °C, 30 °C and 37 °C and the temperature that lead to the
highest phenylalanine production by these modified E. coli was identified. Time studies
were also conducted to determine the time at which the phenylalanine production is the
highest.

2.2.3 Purification of SSIL-Phe
After phenylalanine was produced by the bacteria in a defined growth media, the
bacteria were removed by centrifugation. The remaining supernatant then filtered
through a 0.22 m syringe filter before loading onto a 10 x 250 mm PRP1-C18 column
(Hamilton Corporation, Reno, NV, USA). The column was made up entirely of poly
styrene-divinylbenzene without a stationary phase coating. The sample was run at a
constant flow rate of 3 mL/min and 40 mL batches of supernatant were loaded onto the
column. Sufficient separation of phenylalanine from other components in the media was
achieved without column heating so the column was kept at room temperature (~22 °C).
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Phenylalanine was eluted by an increasing acetonitrile gradient as described in Table 2.2.
Elution of phenylalanine was detected by monitoring absorbance at 254 nm.
Phenylalanine elutes between 45% - 55% acetonitrile. Fractions containing
phenylalanine were pooled and dried to an oily solid with forced air.

Table 2.2: HPLC gradient for phenylalanine purification
Buffer Gradient % Changes
Time (minutes)
H2O with 0.05% TFA

Acetonitrile with 0.05% TFA

0-16

100%

0%

16-22

100%-50%

0%-50%

22-26

50%

50%

26-30

50%-10%

50%-90%

30-34

10%-100%

90%-0%

34-38

100%

0%

2.2.4 Quantification of SSIL-Phe
Phenylalanine produced by the bacterial cells was quantified by UV spectroscopy.
The absorption maximum of phenylalanine is at 254 nm which was used to monitor and
quantify production. The amount of phenylalanine obtained from the fractions after
HPLC purification was estimated by the peak area on the HPLC chromatogram. A
standard curve was plotted using known concentrations of commercially available
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phenylalanine (Acros Organics, Geel, Belgium) against the area of the HPLC peak,
which was then used to extrapolate the concentration of the unknown fraction.

2.2.5 Phenylalanine NMR Spectroscopy
Dried phenylalanine was resuspended in D2O and spectra were acquired at 25 °C
on a 500 MHz Varian Inova spectrometer equipped with a room temperature, triple
resonance probe. One dimensional 1H spectra were acquired with an 8,000 Hz sweep
width centered at 6 ppm. Typically 32k points were collected and 16 transients were
averaged with a recycle delay of 3 seconds. One-dimensional 13C spectra were acquired
with a 26,400 Hz sweep width centered at 100 ppm. Generally, 65.5k points were
collected.
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C-HSQC spectra were acquired using the same 1H parameters except the

number of points was reduced to 2048. Typically 16 transients were averaged per point.
13

C parameters included a sweep width of 17,600 Hz centered at 70 ppm and 128 points

(64 real + 64 imaginary) collected.

2.2.6 Mass Spectrometry
Phenylalanine was derivatized with N-(tert-butyldimethylsilyl)-N-methyltrifluoro-acetamide (MTBSTFA) for GC-MS analysis. A 200 µL sample of 500 µM
phenylalanine in acetonitrile was combined with 200 µL of MTBSTFA also in
acetonitrile and incubated for 4 hours at 55 °C. Following the derivatization, GC-MS
analysis was conducted using an Agilent 6890 series gas chromatograph equipped with
Agilent J&W HP-5MS capillary column directly connected to 5973 Network Mass
Selective Detector. The column was composed of (5%-phenyl)-methylpolysiloxane with
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0.25 µm film thickness and 30 m x 0.25 mm dimensions. Initial oven temperature was
100 °C which was held for 1 min and then raised to 280 °C at a rate of 35 °C/min. The
temperature was further increased to 320 °C at a rate of 40 °C/min and held constant for
2.5 min. The injection volume was 1 μL, injector temperature 300 °C, and the split ratio
5:1. Helium was used as the carrier gas at a constant flow rate of 1 mL/min, initial
pressure of 10.5 psi, and average velocity of 37 cm/sec. Other settings included 280 °C
interface temperature, 230 °C ion source temperature, 150 °C quad temperature, and
electron impact ionization at 70 eV. Mass spectra were recorded in the range of m/z 40450 amu at a rate of 3.5 scans/min for a run time of 9.64 min. The solvent delay was 3.0
min.

2.2.7 Ubiquitin Expression
BL21(DE3)pLysS E. coli were transformed with pET28b carrying the Ubiquitin
gene (Wilson et al. 2011). A single colony was used to inoculate 30 mL of M9 minimal
media supplied with 30 g/mL kanamycin and the culture was grown overnight at 37 C.
In the morning, the starter culture was spun down and cells resuspended in 1 Liter of M9
minimal media with 30 g/mL kanamycin. The culture was grown at 37 C to an OD600
of 0.6. The cells were pelleted by centrifugation and resuspended in optimized M9+20
media (McFeeters 2002) (see Table 2.3) containing 140 mg/L of glyphosate. Labeled
phenylalanine was added as one of the amino acids in the M9+20 media. Cells were then
allowed to grow to an OD600 of 0.8 where expression of Ubiquitin was induced with
IPTG added to a final concentration of 1 mM. Four hours later, cells were harvested and
the cell pellet stored at -80 C until purification. For purification, frozen cell pellets were
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resuspended in ice cold 50 mM sodium phosphate buffer, pH 7.4 with 300 mM NaCl and
approximately 15 mg of lysozyme. The mixture was left to incubate for 30 minutes at
room temperature, followed by sonication. Insoluble material was separated by
centrifugation and Ubiquitin was purified by immobilized metal affinity chromatography.
The supernatant was applied to a HisTrap FF™ Ni2+ affinity column (GE/Amersham,
Little Chalfont, United Kingdom) that was equilibrated with the buffer (50 mM sodium
phosphate, 300 mM NaCl, pH 7.4). Flow rate was kept constant at 2.0 mL/min
throughout the purification. The column was washed with 21 mM imidazole and
Ubiquitin was then eluted with 150 mM imidazole. Ubiquitin containing fractions were
pooled, dialyzed extensively against an NMR buffer of 20 mM NaOAc, 20 µM NaN3, pH
5.0, and concentrated by ultrafiltration.

2.2.8 E. coli Pth1 Expression
BL21(DE3)pLysS E. coli cells were transformed with a pKQV4 plasmid bearing
the E. coli peptidyl-tRNA hydrolase (Pth1) gene. From a single colony, cells were
originally grown in M9 minimal media to an OD600 of 0.4. Cells were then pelleted and
resuspended in the same volume of modified M9+20 (see Table 1.2) containing 140 mg/L
glyphosate. At an OD600 of 0.6, the temperature was dropped to 25 °C and Pth1
expression was initiated with IPTG added to a final concentration of 1 mM. After 16
hours the cells were harvested by centrifugation and stored at -80 C until purification.
Pth1 was purified as previously described (Hughes et al. 2012; Vandavasi et al. 2014;
Taylor-Creel et al. 2014).
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2.2.9 Protein NMR Spectroscopy
Protein NMR data were collected at 25 °C on a 500 MHz Varian Inova
spectrometer equipped with a room temperature probe. For 15N-HSQC data, the 1H
sweep width was 6,000 Hz centered on water (4.77 ppm). For the 15N dimension, the
sweep width was 1,600 Hz with the carrier at 118 ppm. Sixteen transients were collected
for each of the 192 points (96 real + 96 imaginary). The recycle delay was 1.5 seconds.
For non-constant time 13C-HSQC data, 1H parameters were the same as for 15N-HSQC.
Carbon parameters included a sweep width of 17,500 Hz with carrier centered at 70 ppm
for the full carbon spectra and a sweep width of 4,400 Hz centered at 127 ppm for
aromatic spectra. Resonance assignments for Ubiquitin were obtained from the BMRB
ID 5387 (Charles R. Babu et al. 2001). Resonance assignments for E. coli Pth1 were
adapted from BMRB entry 17404 (Giorgi et al. 2011) for the buffer conditions used.

2.2.10 Acid Hydrolysis of Ubiquitin
Protein was hydrolyzed under acidic conditions and the resulting amino acids
were recollected by ion exchange chromatography. The fractions containing the mixture
of amino acids were characterized by GC-MS. The acid hydrolysis and ion exchange
protocols used were derived from previously reported methods (Goh et al. 1987; Early et
al. 1987). To 1 mL of the pure protein (~ 7 mg) in a glass tube, an equal volume of 12 M
HCl was added. The mixture was then autoclaved at 121 °C for 45 minutes and allowed
to rest at room temperature overnight. A volume of the hydrolysate that contained ~200
nmoles of leucine was taken and 2 mL of 1 N acetic acid was added to it. After vortexing
thoroughly, this was applied to a Dowex 50 W-X8 ion exchange resin column. This
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column was prepared by allowing the beads to swell in water overnight and then packed
into a column. The column was then rinsed with 4 column volumes of water before
loading the hydrolyzed sample. After sample loading, the column was once again
washed with 2 column volumes of water three times. Finally, elution was achieved with
3 N ammonium hydroxide. The pH of the eluted fractions was observed to be 12.0.
To prepare samples to be characterized on GC-MS, 100 μL of the hydrolysate was
dried and resuspended in 200 μL of acetonitrile. 200 μL of MTBSTFA reagent was
added to this and incubated at 55 °C for 4 hours. The method used for GC-MS analysis
was the same as described for phenylalanine in section 2.2.6.

2.3 Results and Discussion
SSIL-Phe with Cα, Cγ and Cε positions 13C labeled was developed to be used for
NMR spectroscopic studies of large macromolecular complexes. A recombinant and
inexpensive means for production of SSIL-Phe was developed. Production yield was
optimized and increased to 30% conversion efficiency. Development of a general
method for incorporation into recombinant proteins and demonstrated compatibility with
ILV methyl labeling increases the utility of the reagent.

2.3.1 Production and Purification of SSIL-Phe
In this section, optimization of conditions for phenylalanine production in
bacterial cells and its purification method are described. The isotope labeling in SSILPhe is then characterized by NMR and GC-MS.
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Industrial production of amino acids has frequently been performed in C.
glutamicum. However, extensive alterations are required for direct use of glycerol as a
carbon source (Rittmann et al. 2008). Therefore, an E. coli system previously engineered
to produce aromatic p-hydroxybenzoic acid (Barker & Frost 2001) was adopted as the
starting point for production of phenylalanine. Elevated secretase activity was retained,
resulting in secretion of phenylalanine into growth media, greatly facilitating purification.
Modifications directing carbon flux to phenylalanine production consisted of replacing
the original ubiC gene in the p2.274 plasmid with E. coli phenylalanine biosynthesis
pathway genes. The combination of tyrB and aroK were previously found to produce the
most phenylalanine (Hames 2014).

2.3.1.1 Purification of Phenylalanine
Purification of phenylalanine was performed via HPLC. The filtered supernatant
from cultures of JB161 cells was loaded onto a C18 column and separated with an
acetonitrile gradient. The retention time for phenylalanine was 27 minutes, as determined
by comparing with a standard phenylalanine solution (Acros Organics, Geel, Belgium)
(Figure 2.2). Phenylalanine from 40 mL of the supernatant was purified with each run
and approximately 13 mg of phenylalanine was obtained per run with the optimum
production conditions. Purity of the fractions was confirmed by NMR spectroscopy and
GC-MS, results of which will be described in section 2.3.1.5.

13

C NMR spectrum

showed that phenylalanine collected from the fractions was highly pure with only α, γ
and ε resonances of phenylalanine. Impurities, if any, were negligible.
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Standard Phe
Culture supernatant

Figure 2.2: HPLC chromatogram of phenylalanine purification.
Absorbance at 254 nm was plotted against retention time. Separation of phenylalanine
from culture supernatant and pure commercial phenylalanine were the same, with
retention times of 27 min

2.3.1.2 UV Quantification
The amount of phenylalanine produced and secreted into the culture medium was
estimated using the HPLC peak area on the chromatogram. Solutions with different
concentrations of phenylalanine were prepared and purified by HPLC. The area of the
phenylalanine peak was plotted against the amount of phenylalanine loaded on the
column to obtain the standard phenylalanine curve. Due to the UV lamp saturation with
increasing concentration of phenylalanine, a polynomial trendline was observed to be a
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better fit for the data than a linear trendline. For quantification, only 5 mL of the
supernatant was loaded on the column each time so that the peak is not broad and over
saturated. The amount of phenylalanine in an unknown sample was calculated from the
equation of the calibration curve obtained with the polynomial fit (Figure 2.3).

Phe Calibration Curve

Peak Area [Arbitrary Units (x106)]

45
y = -2.62x2 + 21.20x - 0.25
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35
30
25
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Poly. (Phe Standard)
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2
3
Amount of Phe [mg]

4

5

Figure 2.3: UV calibration curve for phenylalanine.
Area of the Phe peak was plotted against amount of Phe loaded. Trendline along with the
equation used for estimation of concentration of unknown samples is shown on the chart.

2.3.1.3 Gene Combinations for Best Phenylalanine Yield
Focusing on the bottlenecks from both the common pathway leading to
chorismate, the branched pathway from chorismate to phenylalanine (Ikeda 2006), and
combinations known to elevate tyrosine production (Lütke-Eversloh & Stephanopoulos
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2008), the effects of overexpressing aroC (chorismate synthase), aroK (shikimic acid
kinase), tyrB (tyrosine aminotransferase, which also functions as a phenylalanine
aminotransferase), and ydiB (shikimate dehydrogenase) on phenylalanine production
were determined, Figure 2.4. It was found that overexpressing combinations of these
genes produced more phenylalanine even when minimal changes were observed for
individually overexpressed genes, in agreement with previous studies of tyrosine
production in E. coli (Lütke-Eversloh & Stephanopoulos 2008). Also similar to tyrosine,
the combination of tyrB/ydiB showed considerable increase in production of
phenylalanine. However, the combination of aroK/tyrB produced the most phenylalanine
under all conditions tested and was utilized for subsequent studies. JB161 aroK/tyrB
cells were compared to 31884 cells grown under the same conditions to identify the strain
that produces higher amount of phenylalanine. Along with JB161 cells, phenylalanine
production by 31884 cells was also optimized for different carbon sources at differing
concentrations for a defined period of time. It was found that, under all conditions tested,
modified JB161 aroK/tyrB system produced considerably more phenylalanine than 31884
cells. Hence, the modified JB161 system was determined to be the more suitable strain
for obtaining higher yield of phenylalanine.

40

Figure 2.4: Effect of aromatic amino acid biosynthesis genes on phenylalanine
production. Representative of all conditions tested, the relative production of
phenylalanine is shown for the indicated genes. Standard deviations for triplicate
measurements were less than ±5%.

2.3.1.4 Optimization of SSIL-Phe Production
Carbon sources that could be used for production of SSIL phenylalanine by the E.
coli cells were glucose, glycerol and acetate. Glucose has been extensively utilized for
industrial production of aromatic amino acids including phenylalanine (Báez-Viveros et
al. 2004; Ikeda & Katsumata 1992; Sprenger 2007; Zhou et al. 2010; Wang et al. 2011).
However, current commercial availability is limited to a single 13C labeled site (i.e. 2-13Cglucose, not 2,5-13C-glucose), leading to diminished 13C incorporation in phenylalanine
since only half of the pyruvate from glycolysis would contain 13C. Although glycerol and
acetate 13C labeled at individual sites are commercially available, glycerol resulted in a
much higher yield of phenylalanine compared to acetate. Maximum production yield
efficiency (i.e. grams of phenylalanine obtained per 1 gram of carbon source) was 32%
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for glycerol, 27% for glucose and 10% for acetate. These yield efficiencies were
obtained when the starting concentration of glycerol and glucose provided at 1 g/L, and
the concentration of acetate provided was 5 g/L.
The time required to reach maximum phenylalanine production was different for
each carbon source, fastest for glucose (generally 1.5 days), intermediate for glycerol (3
days), and slowest for acetate (4.5 days) when comparing the same starting amount of
carbon source present in the media. When using glycerol media viscosity is slightly
elevated resulting in slower phenylalanine production. The altered metabolic demands
and differently regulated genes associated with using acetate contributed to lower
production yield even with greater concentration of carbon source provided (Oh et al.
2002). Regardless of conditions, glycerol led to the most efficient phenylalanine
production along with the desired labeling pattern and was thus used as the carbon source
for subsequent studies.
Other investigations to maximize efficiency included studying the impacts of
growth temperature and starting glycerol concentration on phenylalanine production.
The starting concentration of glycerol had the greatest impact on yield efficiency
phenylalanine production. Most notably, lower glycerol concentrations resulted in
greater efficiency in production of phenylalanine with maximal production of 150, 315,
385 and 750 mg of phenylalanine per liter from starting concentrations of 0.5, 1, 2, and 8
grams of glycerol, respectively (Figure 2.5A). This translated to production yield
efficiencies of 30, 31.5, 19.3, and 9.4% (Figure 2.5B). At concentrations below 1 g/L,
however, 13C incorporation markedly decreased indicating the presence of an unlabeled
“carbon reservoir” from the initial growth and accumulation of cell density in unlabeled
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media. However, replacing unlabeled media for initial growth with isotopic labeled
glycerol media to purge the unlabeled reservoir did not result in efficiency gains that
would outweigh the additional cost. Unlike the concentration of glycerol, growth
temperature had a more modest effect on phenylalanine production yield efficiency with
maximized production at 30 °C. Slower rate of production at lower temperature of 30 °C
yielded more phenylalanine production for all concentrations of carbon source tested.
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Figure 2.5A: Time course for phenylalanine production.
Data shows mg of phenylalanine produced per liter of culture media at 24 hour time
intervals with varying concentrations of glycerol provided. The culture with 8 g/L
glycerol consistently became contaminated after 3 days so data collection stopped.
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Figure 2.5B: Conversion yield efficiency at different concentrations of glycerol
provided. Data shows percentage of conversion (grams Phe produced per gram glycerol
provided) at 24 hour time intervals.

No significant change in phenylalanine production was observed by increasing
aeration using baffled flasks or reduced culture volume to flask ratio. Thus, it appears
that batch-fed fermentation would not significantly benefit this application with the
exception of potentially reaching maximum production faster (Thongchuang et al. 2012).
Using MOPS buffered media was reported to significantly increase bacterial production
of tyrosine (Santos & Stephanopoulos 2008), but had no effect on phenylalanine
production in this system. Regardless of growth temperature or glycerol concentration,
maximum phenylalanine production was achieved at 72 ± 6 hours, or approximately 3
days. Increasing the amount of M9 salts or the nitrogen source, ammonium chloride, had
no effect on phenylalanine production. Thus, optimal phenylalanine production
conditions were M9 minimal media with 1 g/L of glycerol (substituting for glucose)
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grown for 3 days at 30 °C which consistently produced over 300 mg of phenylalanine per
liter after purification.

2.3.1.5 Characterization of SSIL-Phe Isotope Incorporation
The identity of phenylalanine as a purified product of the bacterial synthesis and
isotopic incorporation was determined by NMR spectroscopy (Figure 2.6) and mass
spectrometry (Figure 2.8). From NMR, the one dimensional carbon spectrum showed
high levels of 13C incorporation at the Cα, Cγ, and Cε positions of phenylalanine.
Specifically for the 1H-13C sites of interest, 13C incorporation was calculated to be ~95%
for Cα and averaged ~70% for Cε from integrated peak intensities in the 1H spectra.
Whereas Hα is clearly resolved, readily allowing integration of 13C versus 12C coupled
peaks, only the downfield 13C coupled resonance of Hε could be reliably quantified. This
level of 13C isotope incorporation is in agreement with previous characterization of
aromatic amino acids produced in bacteria utilizing glycerol as the sole carbon source
(Lemasters & Cronan 1982).

15

N incorporation was controlled by growth conditions with

>95% incorporation readily achieved using 15N ammonium chloride as the sole nitrogen
source during SSIL-Phe production. Mindful of the potential for vastly different
relaxation rates, in particular for aromatic resonances, 13C incorporation was also
characterized using GC-MS. MTBSTFA derivatives of SSIL-Phe had the same retention
time as commercial phenylalanine and fragmentation patterns for natural abundance
phenylalanine matched expected values from the NIST/EPA/NIH reference library. The
three peaks used for identification of phenylalanine were at 234, 308, and 336 atomic
mass units (amu) (Figure 2.7). For SSIL-Phe an increase in 4 amu was observed owing
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to the heavy 13C and 15N incorporation. The increase in size observed for fragmentation
patterns of SSIL-Phe agreed with the isotope incorporation observed via NMR. Best fits
of simulated 13C incorporation to the isotope distribution of individual fragment peaks
closely matched the NMR derived values.

Figure 2.6: 13C incorporation into SSIL-Phe.
The non-constant time 13C-HSQC spectrum of SSIL-Phe shows the existence of isolated
1
H-13C spin systems at the Cα and Cε carbons with (red) and without (black) 13C
decoupling. The 13C spectrum (left) and 1H spectrum without 13C decoupling (above) are
shown. All phenylalanine peaks are labeled in the 1D spectra.
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C H NO Si
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Figure 2.7: Phenylalanine MTBSTFA derivatives.
Fragments 234, 308, and 336 amu used for identification of Phe are shown.

+4 amu
+4 amu

+4 amu

SSIL-Phe

Phe

Figure 2.8: GC-MS characterization of phenylalanine.
Derivatized natural abundance phenylalanine (left) and 13C-SSIL-Phe (right). The mass
of the fragment is indicated above.
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2.3.2 SSIL-Phe in Recombinant Proteins Produced in Bacteria
Incorporation of SSIL-Phe into bacterially expressed recombinant proteins was
shown in 8.5 kDa protein, Ubiquitin (76 residues, 2 phenylalanine and 1 tyrosine
residues). To show applicability of the method to other systems, recombinant
incorporation was also demonstrated in another protein of different size and aromatic
content, E. coli Pth1 (20 kDa, 194 residues, 11 phenylalanine, 2 tyrosine, and 2
tryptophan residues). Since it was previously reported and we also observed that
negligible differences are found in the degree of 13C and 15N isotope scrambling for
phenylalanine (Krishnarjuna et al. 2011), readouts of reverse labeled 15N-HSQC spectra
(natural abundance phenylalanine in a uniform 15N background) were initially used to
monitor phenylalanine incorporation into recombinant Ubiquitin and Pth1.

2.3.2.1 Direct Amino Acid Supplementation of M9 Minimal Media
As a first attempt to incorporate SSIL-Phe into recombinant proteins, it was added
directly to uniform 15N M9 minimal media. For the expression of both Ubiquitin and E.
coli Pth1, adding 200 mg/L of phenylalanine led to approximately 40% incorporation and
the amount of expressed protein was unaffected. The presence of unlabeled carbon
source in the M9 media interfered with the incorporation of SSIL-Phe into the
recombinant protein. Moreover, considerable isotope scrambling, primarily to tyrosine
and tryptophan and to a lesser extent Asx/Glx residues, was also observed. However,
supplementing the media with increasing concentration of SSIL-Phe did not improve
phenylalanine incorporation much.
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2.3.2.2 Inhibitor to prevent phenylalanine biosynthesis
To prevent biosynthesis of phenylalanine during recombinant protein production
and thereby improve SSIL-Phe incorporation, glyphosate was utilized. Glyphosate is an
inhibitor of 5-enolpyruvyl-shikimate-3-phosphate production, one of the final
intermediates in the common aromatic amino acid biosynthetic pathway. Improved
SSIL-Phe incorporation was achieved by addition of 140 mg/liter glyphosate at an OD600
of 0.6 along with 400 mg/L of phenylalanine and 200 mg/L of tyrosine and tryptophan.
Following this procedure, the highest level of phenylalanine incorporation still only
reached 70%.

2.3.2.3 Improved SSIL-Phe Incorporation with Modified M9
To further improve phenylalanine incorporation into bacterially expressed
recombinant proteins, a strategy using modified M9 minimal media was developed. In
this case, carbon source from the media was completely eliminated and instead all 20
amino acids and 4 nucleotides required for the growth and survival of bacteria were
supplied. Except SSIL-Phe, while rest of the media reagents were unlabeled.
Transformed cells were grown in unlabeled M9 minimal media to generate the initial cell
density. Cells were pelleted and resuspended in an equal volume of modified M9, termed
M9+20 (Table 2.3), containing 140 mg/L glyphosate 30 minutes prior to induction of
protein expression, i.e. at an OD600 of 0.6. This provides sufficient time for the
glyphosate to inhibit any further phenylalanine biosynthesis in the cells. At an OD600 of
0.8, recombinant protein expression was induced as usual. Cells were harvested after the
same amount of time used for expression in regular M9 minimal media.
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Table 2.3: Optimized M9+20 media for SSIL-Phe incorporation into recombinant
expressed proteins in bacteria.
Component

g/L

Sodium Phosphate Dibasic

6.7

Potassium Phosphate Monobasic

3

Sodium Chloride

0.5

Nucleotide Triphosphates (A,U,C,G)

0.04

Phenylalanine (isotope labeled)

0.4

Aspartate, Glutamate, Tyrosine, Tryptophan

0.4

Remaining 15 Amino Acids

0.2

Divalent ions, vitamins, and trace elements
according to (T. Maniatis 1982)

Originally, all 20 amino acids were added at a concentration of 200 mg/L with
only phenylalanine isotopically labeled, a method previously established for site specific
labeling of other amino acids (McFeeters 2002). While the amino acids are generally
more concentrated than reported in other selective isotope labeling studies (Shortle 1994;
Tong et al. 2008), this mixture maintained recombinant protein expression levels and
resulted in high level SSIL-Phe incorporation for all conditions tested. To combat
isotopic scrambling from phenylalanine to tyrosine, aspartate, and glutamate, the
concentration of these amino acids was increased to 400 mg/L. Isotopic scrambling was
reduced to <5% with no reduction in phenylalanine incorporation. Using this approach,
the protein yield remained unchanged compared to regular M9 for both Ubiquitin and E.
coli Pth1.
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2.3.2.4 Recombinant Protein Expression with Incorporation Protocol
Expression of Ubiquitin and E. coli Pth1 was tested by using the incorporation
protocol. Expression vector containing gene for Ubiquitin was transformed into
BL21(DE3)pLysS cells and protein expression was carried out in M9+20 medium with
glyphosate. Expression of the protein was first visualized by SDS-PAGE (Figure 2.9).
MW

-

4 hrs

kDa
130
55
35
25
15
10

Figure 2.9: SDS-PAGE showing expression of Ubiquitin.
The culture samples were taken before (-) and 4 hours after induction with IPTG. Arrow
shows the protein of interest, Ubiquitin.

The cells were then lysed and the expressed protein was purified on a Ni+2 column
by affinity chromatography. FPLC chromatogram is shown in Figure 2.10
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Load

Wash

Elution

Figure 2.10: FPLC chromatogram for purification of Ubiquitin.
Load (Flow through while loading the sample), Wash (column wash after sample
loading), Elution (150 mM Imidazole elution)

Fractions containing Ubiquitin were identified by SDS-PAGE (Figure 2.11),
pooled and dialyzed against an NMR buffer. The dialyzed protein was then concentrated
by ultracentrifugation for NMR studies.
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Figure 2.11: SDS-PAGE for Ubiquitin purification.
Fractions containing Ubiquitin are highlighted. MW (molecular weight marker), T
(lysate), S (soluble fraction), P (insoluble fraction), L (loaded sample), FT (flow
through).

Similarly, E. coli Pth1 was also expressed in BL21(DE3)pLysS cells. Expression
vector containing the gene for Pth1 was transformed into BL21 cells and expressed in a
M9+20 medium with glyphosate. After cell lysis, Pth1 was purified by affinity
chromatography. Fractions containing Pth1 were identified by SDS-PAGE, pooled,
dialyzed against NMR buffer and concentrated. SDS-PAGE showing expression was
shown in Figure 2.12, the chromatogram for purification in Figure 2.13 and SDS-PAGE
for identification of purified Pth1 fractions in Figure 2.14.
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Figure 2.12: SDS-PAGE showing expression of E. coli Pth1.
Samples taken before (-) and after (+) inducing with IPTG. Arrow indicates Pth1.

Figure 2.13: FPLC chromatogram for E. coli Pth1 purification. Load (Flow through
while loading the sample), Wash (column wash after sample loading), Elution (150 mM
Imidazole elution).
54

MW T S P MW FT

Wash

Elute fractions

kDa

70
35
25
15
10

Figure 2.14: SDS-PAGE showing purification of E. coli Pth1.
Arrow indicates Pth1. Pooled fractions were highlighted in red. MW (Marker), T (cell
lysate), S (soluble fraction), P (insoluble fraction), FT (Flow through).

2.3.2.5 Confirmation of SSIL-Phe Incorporation by NMR Spectroscopy
Using the optimized incorporation protocol, SSIL-Phe was incorporated into
recombinant Ubiquitin and 13C HSQC was obtained to confirm incorporation. >95%
phenylalanine incorporation was observed.

13

C HSQC of SSIL-Phe incorporated

Ubiquitin in comparison with uniform 13C labeled Ubiquitin was shown in Figure 2.15
below. Improvement in the spectrum is clearly seen.
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Figure 2.15: Non-constant time 13C-HSQC spectra of Ubiquitin.
Spectra of SSIL-Phe and u-13C Ubiquitin are shown for A) all carbons and B) aromatic
carbons.
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Isotope scrambling from SSIL-Phe to other amino acids was checked by
analyzing the individual amino acids in the recombinant proteins by GC-MS. The
peptide bonds between amino acids in the recombinant protein were hydrolyzed under
acidic conditions. The amino acids were separated by ion exchange chromatography and
derivatized using a MTBSTFA reagent for GC-MS analysis (Appendix B). Minimal
isotope scrambling was observed when incorporated with M9+20 media containing
glyphosate, in agreement with NMR.

2.3.2.6 Compatibility with ILV-Methyl Labeling
To further extend utility of SSIL-Phe, the possibility of simultaneous SSIL-Phe
and ILV-methyl labeling was explored. The simplest approach, substituting the
appropriate α-ketoacid precursors for isoleucine, leucine, and valine in the M9+20 at
concentration used in unmodified M9, proved successful. High level methyl labeling was
achieved with no change observed in SSIL-Phe labeling.

13

C HSQC of Ubiquitin with

SSIL-Phe and ILV labeling showed highest level of incorporation with minimal isotope
scrambling to other residues (Figure 2.16). Thus, simultaneous aromatic-ILV-methyl
labeling is readily achievable.
E. coli Pth1 has 11 Phe residues. Simultaneous incorporation of methyl labeled
ILV residues and SSIL-Phe was attempted in EcPth1 as well. Although the methyl
groups and phenylalanine 1H positions were visible in the 13C HSQC spectrum, not all
of the expected 1Hε positions were resolved (Figure 2.17). In addition to the limited
availability of higher magnetic field strengths (only 500 MHz), the relaxation times for
Pth1 were in the millisecond time range which resulted in broad peaks with low signal-to-
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noise ratio. This was thought to be the major reason for absence of the 1H resonances.
However, the presence of α resonances of phenylalanine residues and methyl groups
indicates incorporation of SSIL-Phe along with methyl labeled ILV residues in the
protein. Thus, the incorporation protocol is applicable to a range of recombinant
expressed proteins and is compatible with ILV labeling.
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Figure 2.16: Non-constant time 13C-HSQC spectra of SSIL-Phe/ILV-methyl Ubiquitin.
Methyl groups of ILV side chains, Hα and Hε of phenylalanine are labeled.
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Figure 2.17: Non-constant time 13C-HSQC spectra of SSIL-Phe/ILV-methyl E. coli Pth1.
Methyl groups of ILV side chains, Hα and Hε of phenylalanine are labeled
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2.4 Conclusion
This work demonstrates an efficient and inexpensive method for production of
SSIL-Phe and its incorporation into recombinant proteins. Production of SSIL-Phe was
achieved in genetically modified bacterial cells making the process easily scalable. The
production conditions were optimized and yield efficiency of production was increased
thereby making this process inexpensive and greatly extending the utility of SSIL-Phe.
Maximum incorporation of SSIL-Phe into recombinantly expressed proteins was
achieved using modified M9 media and an inhibitor of the aromatic biosynthesis
pathway. This general protocol, compatible with ILV methyl labeling, was observed to
be applicable to any protein while resulting in high incorporation with minimal isotope
scrambling.
SSIL-Phe will be a useful tool for NMR studies of large macromolecular
complexes. The aromatic Phe residues are often located in strategic locations at binding
interfaces of proteins, is a useful for probing large systems. These SSIL probes will
complement the existing methyl probes in NMR studies. The incorporation method
compatible with ILV methyl labeling protocol allows simultaneous labeling of SSIL-Phe
and ILV residues thus facilitating obtaining aromatic-aromatic, aromatic-methyl and
methyl-methyl data from the same sample. Additionally, with only α, γ and ε positions
13

C labeled, SSIL-Phe eliminates C-C scalar coupling thereby reducing spectral crowding

and increasing resolution of the individual peaks in the spectra. This also makes
collection of constant time HSQC experiments unnecessary giving an immense advantage
to NMR studies of large, slow-tumbling systems. Overall, SSIL-Phe will help in
obtaining more and well-resolved data from large systems.
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In future, SSIL-Phe can be improved by deuteration of the background protons in
order to increase the signal to noise ratio. Despite the high level of incorporation of
SSIL-Phe, it was observed that incorporation by providing the amino acid is not as
efficient as with using the corresponding α-ketoacid precursor. Reports have shown that
stable isotope incorporation into phenylalanine and tyrosine residues of proteins can be
achieved with considerably lower amount of their ketoacid precursors (Lichtenecker et al.
2013). More importantly, the aromatic ketoacid precursors could be directly added to M9
media, making them readily usable with perdeuteration. Hence, conversion of SSIL-Phe
to its ketoacid precursor will improve the efficiency of incorporation and utility with
perdeuteration. Being a modular and recombinant technique, SSIL can also be extended
to other amino acids of similar interest like tyrosine and tryptophan, one of which
(production of SSIL-Tyr) will also be investigated in this research.
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CHAPTER 3

SITE SPECIFIC ISOTOPE LABELED TYROSINE

3.1 Background
Like SSIL-Phe, SSIL-Tyr is 13C labeled at Cα, Cγ and Cε positions (Figure 1.8B).
The isolated 1H-13C spins created due to alternate carbon labeling improves NMR spectra
when incorporated into proteins by reducing spectral crowding and line broadening.
Additionally, since 13C chemical shifts of ε carbons are distinct for phenylalanine and
tyrosine, Phe and Tyr assignments will be possible even with simultaneous labeling in the
sample. SSIL-Tyr can be produced inexpensively by bacterial cultures grown with 2- 13C
glycerol as the sole carbon source which results in 13C labeling at Cα, Cγ and Cε
positions.
Genetic modifications to the phenylalanine producing JB161 cells were initially
considered to obtain a tyrosine producing cell strain. However, JB161 cells resulted in
poor production of tyrosine due to the overexpression of aroF isozyme of DAHP
synthase (feedback inhibited by tyrosine) and a genetic mutation in the tyrA gene. Hence,
two alternatively engineered strains obtained from Stephanopoulos Lab were used for
production of tyrosine, TyrT1 and TyrT2 (Lütke-Eversloh & Stephanopoulos 2007).
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These strains were developed from E. coli K12 ΔtyrR strains. The lack of tyrosine
repressor genes allows increased production of tyrosine in these strains. The TyrT1 strain
harbors overexpressed genes of feedback resistant mutants of aroG and tyrA. Strain
TyrT2 was a modified version of strain TyrT1 in that expression levels of ppsA and tktA
genes were also elevated in these cells for increased precursor supply (phosphoenol
pyruvate and erythrose-4-phosphate). Both TyrT1 and TyrT2 produced much more
tyrosine than JB161 cells with further modifications and hence tyrosine production was
optimized using these strains.
Yields obtained from both strains were compared to identify the strain suitable for
maximum tyrosine production and then conditions for maximum production of tyrosine
using that strain were optimized. Using the optimum strain and production conditions,
SSIL-Tyr was produced by providing 2-13C glycerol as the sole carbon source in the
growth medium. Since the system was engineered to secrete the produced tyrosine into
the medium, purification of tyrosine was straightforward. Isotope labeling pattern was
characterized by NMR spectroscopy and GC-MS. Recombinant, inexpensive means of
production of SSIL-Tyr increases economic feasibility and thus utility of this reagent.

3.2 Methods
The following methods were used for the production, purification and
characterization of SSIL-Tyr in E. coli cells.
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3.2.1 Optimization and Production of SSIL-Tyrosine
For achieving maximum yield of tyrosine per liter of batch culture, production
parameters were optimized. Modified JB161 cells, TyrT1 and TyrT2 strain E. coli cells
were compared to assess and identify the strain best suited for tyrosine production. Using
the strain that produced highest amount of tyrosine, experiments were conducted to
optimize the temperature, cell density at the time of induction and hours of fermentation.
All variations for the conditions tested were based on the previous reports of tyrosine
production using these strains (Lütke-Eversloh & Stephanopoulos 2007; Lütke-Eversloh
& Stephanopoulos 2008). Yields were compared when the cultures were incubated at 30
°C and 37 °C. Another parameter, cell density at the time of induction, was varied
between 0.6 and 0.8. Scale up procedure for large scale cultures was also optimized to
achieve higher yields. Production curve was also analyzed to identify the number of
hours required to obtain highest tyrosine yield.
Using the optimum conditions, SSIL tyrosine production was achieved according
to the following procedure. The tyrosine producing E. coli cells from the frozen cell
stock were grown to saturation in LB with 50 μg/mL streptomycin and then resuspended
in fresh LB such that OD600 of the culture is about 0.1. Once the cells grow to an OD600
of 0.4, they were centrifuged and resuspended in an equal volume of M9 minimal media
with 2 g/L 2-13C glycerol. At OD600 of 0.8, the cells were induced for tyrosine expression
with 0.5 mM IPTG. A temperature of 37 °C is maintained throughout for tyrosine
production. After 20 hours, the cultures were harvested by centrifugation. Since tyrosine
is excreted into the medium by these cells, the tyrosine accumulated in the supernatant is
purified by HPLC.
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3.2.3 Purification of Tyrosine
The culture supernatant containing tyrosine was obtained after clarification of
cells. The pH of the supernatant was then lowered to 2.0 to increase solubility of tyrosine
and it was then purified on a PRP1-C18 column (Hamilton Corporation, Reno, NV, USA)
(Column composition described in section 2.2.3). The flow rate was kept constant at 3
mL/min and tyrosine was eluted with an acetonitrile gradient. The solvents and the
gradient used for purification were the same as described in Table 2.2 of section 2.2.3.
However, since the absorption maximum of tyrosine is 278 nm as opposed to the 254 nm
for phenylalanine, the detection wavelength for this HPLC protocol was changed to 278
nm. Fractions containing tyrosine were pooled and air-dried.

3.2.4 Quantification
Solubility of tyrosine is very low in aqueous solution. A highly basic pH is
required to increase the solubility of tyrosine in water. Solubility of tyrosine in water is
0.45 mg/mL. But at pH 10, solubility increases to 3.8 mg/mL (Hitchcock 1924). Since
such a high pH is harmful for the HPLC column, a standard tyrosine concentration curve
was obtained by UV spectrometry. Tyrosine solutions of varying concentrations were
prepared and their absorbance at 280 nm was plotted against the concentration of tyrosine
to obtain the standard curve. Absorbance of the HPLC fractions was then used calculate
the concentration of tyrosine by extrapolating from the standard curve. Amount of
tyrosine produced in the culture was then calculated from the concentration of tyrosine in
the culture.
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3.2.5 Tyrosine NMR Spectroscopy
For NMR samples, tyrosine fractions from HPLC were pooled, dried and
resuspended in D2O. The NMR spectra were obtained on a 500 MHz Varian Inova
spectrometer using the method as that for phenylalanine described in section 2.2.5.

3.2.6 Mass Spectrometry
For GC-MS analysis, the dried HPLC fractions were resuspended in 200 μL of
acetonitrile and 200 μL of MTBSTFA was added to it. The mixture was then incubated
at 100 °C for 4 hours. Following derivatization, the samples were analyzed on Agilent
6890 series gas chromatograph using the same method as for phenylalanine described in
section 2.2.6.

3.3 Results and Discussion
Site specific isotope labeling of Tyr with α, γ and ε carbons 13C labeled was
achieved. Production of SSIL-Tyr using recombinant bacteria reduced the cost and
extended utility of the reagents. Optimizing the conditions for production of tyrosine in
the recombinant bacteria increased the Tyr yield to ~200 mg per liter of the culture
medium.

3.3.1 Comparison of Tyrosine Producing Strains
Modified JB161, TyrT1 and TyrT2 strains were compared for their tyrosine
producing capabilities. The modified JB161 cells resulted in minor amount of tyrosine
production and resulted in a mixture of phenylalanine and tyrosine. Hence, the other

67

strains were selected for optimization of production conditions. TyrT1 and TyrT2 strains
are both tyrosine producing strains with streptomycin antibiotic marker. The optimized
growth conditions were quite different from the JB161 SSIL-Phe production. For SSILTyr, the cells were grown in M9 minimal media with 50 μg/mL streptomycin and 2 g/L
of glycerol as the carbon source. At OD600 of 0.6 when grown at 37 °C, the cultures were
induced with 0.5 mM IPTG. After 20 hours, the culture medium was clarified of the cells
and tyrosine in the culture supernatant was then purified by HPLC and confirmed by 1HNMR. It was observed that TyrT2 strain with the genes for increased precursor supply
were better producers of tyrosine as compared to TyrT1 strain (Figure 3.1). Amount of
tyrosine produced by each strain was compared by comparing the intensity of the δ and ε
proton peaks on the 1D 1H NMR spectrum while keeping the intensity of the reference
water peak at 4.77 ppm constant.
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A)

δ ε

B)

δ ε

Figure 3.1: Comparison of tyrosine production by TyrT1 and TyrT2.
A) 1D 1H spectrum of culture supernatant of TyrT1 strain and B) 1D 1H spectrum of
culture supernatant of TyrT2 strain
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3.3.2 Growth Medium for Tyrosine Production
These strains previously were reported to be grown in MOPS buffered minimal
media with 5 g/L glucose and 2 g/L NH4Cl (Lütke-Eversloh & Stephanopoulos 2008).
But lower concentrations of carbon source provided to bacteria resulted in higher
efficiency of production of SSIL amino acids (Section 2.3.1.5). Hence, initial
experiments to analyze the capability of tyrosine production by the strains were carried
out in M9 minimal media (Table 2.1) with 2 g/L glycerol as the sole carbon source in 30
mL batch cultures. Nevertheless, effect of MOPS buffered media on tyrosine production
was also tested when glycerol was the carbon source provided. Composition of MOPS
minimal media with glycerol as the carbon source is shown in Table 3.1. Other
parameters were kept constant with cell density for induction at OD600 of 0.6, temperature
of 37 °C and the cells were harvested after 20 hours. However, increase in the amount of
tyrosine produced was not observed when using the MOPS media. Hence, M9 minimal
media with 2-13C glycerol as the sole carbon source was utilized for the efficient
production of SSIL-Tyr.
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Table 3.1: MOPS Media composition (Neidhardt et al. 1974). MOPS, tricine and ferrous
sulphate solutions were prepared fresh while the others were made into a stock solution
and stored.
Component

Concentration

MOPS

8.36 g/L

Tricine

0.72 g/L
pH set to 7.4 with 10 M KOH

Ferrous sulphate

0.0028 g/L

Ammonium chloride

2 g/L

Potassium sulphate

0.05 g/L

Calcium chloride

10 μL of 1M

Magnesium chloride

0.1 g/L

Sodium chloride

2.9 g/L

Glycerol

2 g/L

Potassium phosphate dibasic

0.0173 g/L

3.3.3 Optimization of SSIL-Tyr Production Conditions
After confirming that the production of tyrosine by TyrT2 cells was greater than
with TyrT1 cells, other variables were optimized. Although M9 with glycerol resulted in
better tyrosine yield than MOPS minimal media with glycerol, choosing glucose as the
carbon source increased the yield. However, 2-13C glycerol was chosen to achieve the
desired labeling pattern due to the commercial unavailability of 2,5-13C glucose. The
next parameter that was optimized was length of expression time. Suitable temperature
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for the growth and tyrosine expression of these cells is 37 °C. The higher temperature
causes the yield of tyrosine production to peak at a shorter time of 20 hours.
The culture volume used was 30 mL in a 125 mL flask thus maintaining the 4x
aeration rate. However, it was also observed that the lag phase upon switching to the
minimal media from LB was long, resulting in no tyrosine production in batch cultures
larger than 30 mL in volume (Figure 3.2). Hence, to achieve higher amount of SSIL-Tyr
production, the cells were allowed to reach OD600 of 0.4 in LB at which point they were
resuspended in an equal volume of M9. The bacterial cells were then allowed to grow to
OD600 of 0.8 in the M9 and then tyrosine expression was induced with 0.5 mM IPTG.
Expression was carried out at 37 °C for 20 hours. Production of tyrosine was detected by
characterizing the dried tyrosine HPLC fractions by NMR spectroscopy.
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Figure 3.2: Optimization of tyrosine production in large culture volumes.
1D 1H spectrum of culture supernatant of TyrT2 strain when induced without doubling in
M9. Missing peaks around 7 ppm indicate no tyrosine production

3.3.4 Purification of Tyrosine
After tyrosine production in cultures using the optimized production conditions,
the culture supernatant containing tyrosine was obtained by clarifying the cells. Before
loading on the PRP1-C18 column for purification, the pH of the supernatant was adjusted
to 2.0 with trifluoroacetic acid in order to increase solubility of tyrosine. Tyrosine was
eluted with acetonitrile and retention time for tyrosine was also found to be 27 min by
comparison with a standard tyrosine solution (Figure 3.3). It elutes at approximately
50% acetonitrile concentration. Fractions containing tyrosine were collected and dried
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with forced air. Although retention time on this column was found to be the same for
both phenylalanine and tyrosine, absence of phenylalanine production by these strains

Abs @ 278 nm

was confirmed by both NMR spectroscopy and GC-MS (results shown in section 3.3.6).

Retention Time (min)
Figure 3.3: HPLC chromatogram for tyrosine purification.
Purification of tyrosine from culture supernatant (Red) was compared to pure tyrosine
(Sigma Aldrich) run on the column (Green) and retention time was identified as 27 min.
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3.3.5 Quantification
The amount of tyrosine in the HPLC fractions was estimated using the UV
absorbance at 278 nm. Solutions of varying concentrations of tyrosine were prepared and
absorbance at 278 nm was measured to obtain a calibration curve (Figure 3.4). To
measure the absorbance of the tyrosine standard samples of different concentrations,
dilutions of each of those samples were prepared such that the absorbance value lies
between 0.1 and 1.0. Actual absorbance of the sample was then calculated by
multiplication with the dilution factor. Due to this procedure, a linear increasing trend
was observed for the tyrosine standard unlike the apparent saturation of the exponential
trend as seen for the phenylalanine standard obtained using the HPLC peak area.
However, low solubility of tyrosine led to the usage of this method for its quantification.
After purification of the culture supernatant on HPLC, a dilution of the fractions
was made such that absorbance value lies between 0.1 and 1.0 and the absorbance of the
tyrosine fractions was measured by multiplication of the dilution factor. Concentration of
tyrosine in the fractions was calculated from the equation of the standard curve. Amount
of tyrosine in the known volume of pooled fractions was then calculated from this
concentration. With the optimized conditions, the amount of tyrosine obtained from the
cultures was ~200 mg per liter of culture volume.
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Tyr standard
8.00

y = 1.68x - 0.25

7.00

Abs @ 278 nm

6.00
5.00
4.00

Tyr standard

3.00

Linear (Tyr standard)

2.00
1.00
0.00
0
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2

3

4
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Figure 3.4: UV calibration curve for Tyrosine.
Absorbance at 278 nm plotted against concentration. Linear trend line and equation used
for estimation of concentration of unknown samples is shown on the chart.

3.3.6 Characterization of Isotope Incorporation in SSIL-Tyr
The production and purification of tyrosine along with the desired pattern of
isotope incorporation was confirmed by NMR spectroscopy (Figure 3.5). Distinct
chemical shifts of 1Hδ and 1Hε peaks at 7.2 and 6.9 ppm respectively in the one
dimensional 1H NMR spectrum were used to detect the presence of tyrosine. Absence of
phenylalanine is indicated by the absence of proton peaks at 7.4 ppm. As seen in figure
3.5, splitting of the 1Hε peak in the 1D 1H spectrum indicates 13C incorporation at the ε
position. Additionally, one dimensional carbon NMR spectrum shows 13C incorporation
at only the desired α, γ and ε positions in the tyrosine. The 13C HSQC consisted of two
peaks at the Hα – Cα and Hε – Cε positions which confirmed the isotope labeling pattern
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in SSIL-Tyr. However, though other aromatic amino acids production was not detected,
both one dimensional carbon and proton spectra indicate minor amount of impurities
collected in the HPLC fractions along with tyrosine.

Figure 3.5: Non-constant time 13C-HSQC spectrum of SSIL-Tyr.
Isolated 1H-13C spin systems are seen at the Cα and Cε carbons. The 13C spectrum (left)
and 1H spectrum without 13C decoupling (above) are shown. All tyrosine peaks are labeled
in the 1D spectra.
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SSIL-Tyr was also characterized by GC-MS (Figure 3.7). Retention time for
MTBSTFA derivatives of SSIL-Tyr was identified by comparison with MTBSTFA
derivatives of commercial tyrosine. Fragmentation patterns for natural abundance
tyrosine matched expected values from the NIST/EPA/NIH reference library. The three
peaks used for the identification of tyrosine were at 302, 364 and 438 atomic mass units
(amu). Tyrosine derivatives resulting in these were shown in Figure 3.6. The increase in
size of the fragments of SSIL-Tyr agreed with the expected isotope incorporation.

C H NO Si
14 32

2

2

302 Da

C H OSi
13 22

222 Da

C H O Si
7 15 2

159 Da

C H NOSi
20 38

2

364 Da

C H NO Si
23 44

3

2

438 Da

Figure 3.6: MTBSTFA derivatives of Tyrosine.
Fragments of size 302, 364 and 438 amu used for identification of tyrosine are shown.

302 peak arises from the MTBSTFA derivative of the backbone of the amino
acids. An increase in 2 amu was observed for this derivative in SSIL-Tyr (Figure 3.7)
indicating the 13C incorporation at Cα and 15N incorporation at the amino position of the
amino acid. An increase of 4 amu for the other two derivatives and detailed analysis into
the pathway for tyrosine production from 2-13C-glycerol indicates partial 13C
incorporation at Cε position which was estimated to be 60%.
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80
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80

60

40

60

40
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20

20
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0
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0
289

320

350
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440

289

320

350

381

412

440

SSIL Tyrosine

Tyrosine

Figure 3.7: GC-MS fragmentation pattern of tyrosine.
Derivatized natural abundance tyrosine (left) and SSIL-Tyr (right). The mass of the
fragment is indicated above.

3.4 Conclusion
Successful production of SSIL-Tyr in recombinant bacteria was demonstrated.
The engineered E. coli strain, TyrT2, led to highest amount of tyrosine production among
the strains compared and the conditions for tyrosine production using that strain were
optimized to obtain maximum amount of tyrosine. Similar to recombinant SSIL-Phe
production, SSIL-Tyr production is also an efficient and inexpensive method.
Furthermore, since aromatic amino acid tyrosine was also reported to be found with high
frequency in active sites and protein interaction interfaces (Bogan & Thorn 1998), SSILTyr is another additional reagent that can be used to study large macromolecular systems
by NMR spectroscopy. With their distinct 13Cε chemical shifts and general incorporation
protocol described in Chapter 2, simultaneous labeling of Phe and Tyr within a sample
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can be achieved. In addition, compatibility of the method with ILV methyl labeling
allows obtaining aromatic and methyl information from a single NMR sample.
In future, the possibility for improvement in SSIL-Tyr production will be assessed
by testing the effect of elevated expression of other aromatic biosynthesis pathway genes
in TyrT2 strains. Conversion to the corresponding ketoacid precursor for more efficient
incorporation into recombinant proteins can also be investigated. Deuteration of
background protons will improve signal to noise ratio and further increase applicability of
these reagents.
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CHAPTER 4

SPECIFIC PEPTIDE PEPTIDYL-tRNA

4.1 Background
Pth1 is a protein of interest due to its potential to be an antibiotic target. Many
Pth1 apo structures have been fully resolved (Emmanuelle Schmitt et al. 1997; Pulavarti
et al. 2008; Hughes et al. 2012; Clarke et al. 2011) along with a low resolution structure
of the complex. The overall shape of the complex was obtained by SANS data, however,
some ambiguity was observed in the peptide and anticodon region due to heterogeneity of
the substrate molecule (Hames et al. 2013). The lack of a high resolution structure of the
complex leaves gaps in the understanding of the enzyme-substrate interaction. Moreover,
small molecule docking studies to the apo-protein poorly predict inhibitory compounds
(Ferguson et al. 2016). To help discover and develop small molecule Pth1 inhibitors, and
potentially a new class of antibiotics, a high resolution structure of the Pth1 complex is
vital. Although various regions of the enzyme and substrate interactions were identified
by study the protein complexed with modified aminoacyl tRNA (Shiloach et al. 1975;
Giorgi et al. 2011; Kaushik et al. 2013; Ito et al. 2012), there have been no reports on the
protein in complex with its natural substrate, peptidyl-tRNA. This can be accounted to
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the lack of a means for producing large quantities of a homogenous peptidyl-tRNA.
Thus, the goal of this part of the research is to produce milligram quantities of specific
peptide peptidyl-tRNA for use in studying the Pth1:peptidyl tRNA complex. Specific
peptide peptidyl-tRNA is a tRNA molecule with a peptide of specific sequence attached
at the CCA end. Larger quantities of this homogenous substrate molecule will be useful
for high resolution structure/function studies of the Pth1:peptidyl tRNA complex using a
catalytically inactive Pth1 mutant. This mutant Pth1 has the mutation of His to Arg at
position 20. This mutation in His residue, essential for the catalytic activity of the
enzyme (Ito et al. 2012), results in the enzyme binding to the substrate but not
hydrolyzing the peptide from the tRNA.
In order to produce milligram quantities, recombinant expression of peptidyl
tRNA in bacteria was first attempted. The cells used for expression were PRFB2 cells
(Kawakami et al. 1988). The prfb gene in this E. coli strain is mutated such that release
factor 2 (RF2), responsible for translation termination at UGA and UAA codons, is
inactive at 42 °C. This mutation leads to conditionally lethal mutants, viable at 30 °C but
not at 42 °C. For production of peptidyl tRNA, a vector with the gene construct for the
specific peptide will be transformed into the cells. After growth and induction at 30 °C,
the temperature will be shifted to 42 °C and the cultures harvested after 1 hour. The
temperature shift stalls termination of translation resulting in the accumulation of
peptidyl tRNA. The accumulated peptidyl tRNA can be obtained by lysing the cells and
purifying the peptidyl tRNA from the soluble fraction. This method yielded little if any
of the desired specific peptide peptidyl-tRNA so alternatives were tested.
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An alternate method tested to produce large quantities of tRNA is by in vitro
transcription. Template DNA consisting of the gene for tRNAPhe under the control of a
T7 promoter will be transcribed in vitro using a T7 RNA polymerase. The transcribed
tRNAPhe can then be charged with the phenylalanine using the corresponding aminoacyl
tRNA synthetase. Specific peptide peptidyl-tRNA can then potentially be synthesized by
adding a chain of poly amino acids to this aminoacylated tRNA. The methods used and
results achieved are described below.

4.2 Methods
In this section, design and cloning of the gene construct, transformation and
expression in PrfB2 cells and in vitro transcription will be described.

4.2.1 Designing the Specific Peptide Peptidyl-tRNA
The construct for expression of peptidyl tRNA, as shown in Figure 4.1, was
designed such that it includes a promoter, sequences for easy detection and purification of
the gene product and a short peptide sequence amenable for biomolecular NMR where
SSIL phenylalanine can be readily incorporated and utilized.

Figure 4.1: Gene construct synthesized for expression of specific peptide peptidyl-tRNA.
* indicates a stop codon

Tac, a strong hybrid bacterial promoter, was used as the promoter sequence for
this gene. The tac promoter is a functional hybrid of the bacterial lac UV5 and trp
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promoters. It was shown to have higher expression levels than either of these two
individual promoters (De Boer et al. 1983). Since the PrfB2 cells used do not contain a
T7 polymerase for expressing the genes under its control, the tac promoter was chosen.
Downstream of the promoter sequence is the tRNAPhe sequence. Since the last residue of
the peptide is a phenylalanine, this could potentially lead to tRNAPhe starvation. Thus,
tRNAPhe was included in the construct for overexpression of tRNAPhe thereby avoiding
tRNAPhe starvation. The increased levels of tRNAPhe will help ensure higher level
expression of the desired specific peptide peptidyl tRNA. To facilitate detection of the
expressed peptidyl-tRNA, a myc-tag was included in the gene. A myc tag is derived from
the c-myc gene product and has commercially available antibodies for detection of the
gene expression by Western blot. Downstream to this tag, a polyhistidine tag comprising
of 6 His residues was added to allow easy purification by affinity chromatography. The
last sequence of this gene is a short sequence coding for 5 amino acid residues and the
stop codons. The amino acids for the short sequence were chosen to facilitate NMR
studies, but also proposed to fill the Pth1 substrate binding site. The last residue of the
gene is Phe taking advantage of SSIL phenylalanine to know high resolution crystal
structure of tRNAPhe. A factor X site between the His tag and the peptide sequence can
be used to cleave the detection and purification tags from the peptide sequence thus
resulting in tRNAPhe with a small 5 residue peptide attached at the CCA end. Restriction
sites BglII and BamHI were introduced on either side of the sequence to facilitate
cloning. An XbaI site was placed after the tRNAPhe sequence for separation of the tRNA
and peptide. The nucleotide sequence of the designed gene is shown in Figure 4.2 below.
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AGATCTGAGCTGTTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTG
BglII
-35 region
-10 region
Tac promoter
AGCGGATAACAATTTCAAAGAAATTTGATTGACGAGACGAGGCGAATCAGGT
Lac operator
TTAATGCGCCCCGTTGCCCGGATAGCTCAGTCGGTAGAGCAGGGGATTGAAA
tRNAPhe
ATCCCCGTGTCCTTGGTTCGATTCCGAGTCCGGGCACCACTAATTCTTAAGAA

CCCGCCCACAAGGCGGGTTTTTGCTTTTGGATCTGACAATAACCTTCACGAAA

AAATCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATGGAAC
XbaI
RBS
M E Q
AGAAACTGATTAGCGAAGAAGACCTGCATCATCATCATCATCATACTGAAGG
K
L I S
E
E
D
L H H H H H H T
E
G
Myc-tag
His-tag
Factor Xa
TCGTATCCTGGGCGCGTTCTGATAACTGACGATCTGCCTCGCGCGTTTCGGTG
R
I L G A
F *
*
T7 terminator
ATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGGATCCGAATTCGAGCT
BamHI
Figure 4.2: Sequence of the gene synthesized for expression of specific peptide peptidyltRNA.

4.2.2 Cloning into Expression Vector
The full, designed gene sequence for peptidyl tRNA was ordered from GenScript
(New Jersey, USA). The gene which was received in a pUC57 cloning vector was
excised and ligated into pET28b expression vector. pUC57 containing the gene and
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pET28b were digested with BglII and BamHI. The protocol for restriction digest is given
below.

Restriction digest protocol
1.5 μL
1.5 μL
1.5 μL
~800 ng
to 15 μL

10X Fast Digest buffer (Thermo Fisher)
BglII
BamHI
Plasmid DNA
dH2O

The enzymes used were at a concentration of 10 Units/μL (ThermoFisher) and the
digestion reaction was carried out at 37 °C for 30 min. The DNA fragments were
separated on a 1% agarose gel. The cut gene fragment and pET28b vector were extracted
from the gel and purified using a GeneJET Gel extraction kit (ThermoFisher Scientific).
The gene was then ligated into pET28b according to the following ligation reaction
procedure.

Ligation protocol
2 μL
4 μL
12 μL
2 μL

10X Ligation buffer (ThermoFisher)
pET28b (BglII/BamHI cut)
Gene fragment (BglII/BamHI cut)
T4 DNA ligase

Concentration of the T4 DNA ligase used was 5 Units/μL. Ligation reactions
were carried out at room temperature overnight. Upon completion, the ligated DNA was
transformed into competent JM109 cells. The transformed cells were plated on the
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antibiotic containing LB agar for selection. A single colony was picked, grown in LB
media and the DNA was extracted and purified from it using GeneJET plasmid extraction
kit (ThermoFisher Scientific).

4.2.3 Expression of Peptidyl tRNA
PrfB2 cells were transformed with pET28b containing peptidyl tRNA gene.
Transformed cells were plated on LB agar plates with 30 μg/mL kanamycin and
incubated at 30 °C overnight. A single colony from the plate was grown in LB media
until the desired optical density at 600 nm was reached. The culture was then induced
with 1 mM IPTG. Temperature was immediately shifted to 42 °C and samples were
collected after every 15 minutes for a period of two hours. To optimize expression
conditions, induction was tested at OD600 of 0.4, 0.5 and 0.6. For cell samples, cells from
50 μL culture were resuspended in 40 μL of loading buffer.

4.2.4 Western Blot Analyses
For specific detection of the expressed peptidyl tRNA, a Western blot was used.
The cells from the samples are lysed in Tris-HCl, pH 6.8 with 20% SDS and βmercaptoethanol and the proteins are separated by SDS-PAGE. Since the peptide
consists of a myc-tag and his-tag, antibodies against either could be used for detection.
The proteins in the cell samples separated by electrophoresis were transferred on to a
PVDF membrane using a mini trans-blot cell (Bio-Rad Laboratories, CA, USA) at 30 V
for 16 hours in a transfer buffer containing 20% methanol. The membrane was blocked
for 2 hours in blocking buffer (50 mM Tris, 150 mM NaCl, 0.1% Triton X-100, 2% BSA,
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5% milk, pH 7.6). It was then incubated with anti c-myc/anti-His antibody (Abgent
Antibodies) for 1 hour and then with horseradish peroxidase-linked secondary goat antimouse antibody (BD Biosciences, New Jersey, USA) for 1 hour. Expression of the
peptidyl-tRNA construct was detected by detection of immuno-fluorescence using BioRad Chemiluminescence kit.

4.2.5 Small Peptide Gel Optimization
The peptide that was designed is a 26 residue peptide. Initial PAGE gel images of
the cell culture samples showed that a 12% polyacrylamide gel containing SDS may not
be suitable for the visualizing the expressed peptide. Hence, other PAGE resolving gels
with varying concentrations of the acrylamide and crosslinking were tested to identify the
one best suited to resolve small peptides ~3 kDa in size.

4.2.6 Removal of tRNAPhe sequence
As seen from the gene sequence in Figure 29, XbaI restriction site is places
downstream of the tRNAPhe sequence. To remove this tRNAPhe and test expression of the
peptide sequence, the pET28b vector with inserted gene sequence was digested with XbaI
and XhoI. An empty pET28b vector was also digested with these two enzymes. The
small gene fragment which is 235 bp long and the large fragment of the double digested
empty pET28b were separated from their respective reactions on 1% agarose gel by
electrophoresis. These fragments were excised and extracted from the gel using a
GeneJET gel extraction kit. Restriction digestion reactions and ligation reaction of the
two fragments were set up according to the procedure described in section 4.2.2 above.
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4.2.7 In vitro transcription
tRNAPhe was synthesized by in vitro transcription using a Promega RiboMAXTM
T7 Express kit. Oligonucleotide primers were synthesized and put together for template
preparation. The oligonucleotides consisted of a T7 promoter for the binding of the
polymerase and a 76 bp tRNA sequence as shown below. T7 promoter is shown in green.

Sense strand 5’ – 3’
TAATACGACTCACTATAGGGCCCGGATAGCTCAGTCGGTAGAGCAGGGGATT
GAAAATCCCCGTGTCCTTGGTTCGATTCCGAGTCCGGGCACCA

Complementary 5’ – 3’
TGGTGCCCGGACTCGGAATCGAACCAAGGACACGGGGATTTTCAATCCCCTG
CTCTACCGACTGAGCTATCCGGGCCCTATAGTGAGTCGTATTA

Transcription templates were prepared by annealing the complementary
oligonucleotides together. Annealing conditions were as follows: mixture of the two
strands was incubated at 95 °C for 5 min and then allowed to gradually cool to 25 °C. In
vitro transcription reactions set up are shown in Table 4.1.
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Table 4.1: In vitro transcription reactions protocol
T7 Reaction Components

Sample Reaction

Control Reaction

RiboMAXTM Express T7 2X buffer

25 μL

10 μL

Linear DNA template

20 μL

-

pGEM Express positive control template

-

1 μL

Nuclease-free water

-

7 μL

Enzyme mix, T7 Express

5 μL

2 μL

Final volume

50 μL

20 μL

The transcription reactions were mixed gently and allowed to proceed at 37 °C for
1 hour. After 1 hour, the template DNA was removed by adding RQ1 RNase-Free
DNase and then incubating at 37 °C for 15 min. A sample of these transcription reactions
were run on a 6.5% polyacrylamide gel containing 8 M urea. The gel was then stained
with methylene blue to visualize the bands. tRNA from the remaining reaction was
phenol:chloroform extracted and ethanol precipitated according to the following
procedure. Equal volume of phenol:chloroform (25:1) was added to the transcription
reaction mixture, vortexed and microcentrifuged. Upper, aqueous phase was transferred
to a fresh tube and 1 volume of chloroform was added, vortexed and centrifuged. Upper
aqueous phase was again transferred to a fresh tube and 0.1 volume of 3 M sodium
acetate and 1 volume of isopropanol were then added to it. It was mixed and incubated
on ice for 5 minutes. After centrifuging, the pellet was washed with 70 % ethanol and the
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RNA was resuspended in Nuclease-Free water in a volume identical to the transcription
reaction. tRNA was stored at -80 °C.

4.2.8 E. coli Phenylalanine tRNA Synthetase Expression and Purification
The expression plasmid pQE31 with E. coli phenylalanine tRNA synthetase
(EcFRS) gene was obtained from the Safro lab (Mermershtain et al. 2011). This plasmid
was transformed into XL10 gold ultracompetent cells (Agilent Technologies). The cells
were grown in LB with 25 μg/mL carbenicillin at 37 °C. At OD600 between 0.6 – 0.8,
temperature of the culture was lowered to 25 °C and expression was induced with 0.5
mM IPTG overnight. The cells were then harvested by centrifugation at 4,000 rpm and
the pellet was stored at -80 °C.
For purification, the cell pellet was resuspended in 20 mL of Buffer A (20 mM
Tris, 300 mM NaCl, 5 mM Imidazole, 10% glycerol, pH 8.0) and sonicated for 5
minutes. The soluble fraction was obtained by centrifugation at 10,000 rpm for 30 min.
EcFRS was then purified by affinity chromatography on a HisTrapFF column. The
column was washed and equilibrated with buffer A before loading the soluble fraction of
the cell lysate onto it. It was then washed with 25 mM imidazole and then the protein
was eluted with 300 mM imidazole.

4.3 Results and Discussion
To produce milligram quantities of homogenous specific peptide peptidyl tRNA,
a gene with the necessary elements for expression of the peptidyl tRNA and designed
peptide was cloned into an expression vector and expression was induced in E. coli cells
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with a temperature sensitive RF2 mutant. This strategy did not prove successful, so an
alternative method utilizing in vitro transcription to make large quantities of tRNAPhe was
also tested. After producing the tRNA, subsequently charging using a phenylalanyl
tRNA synthetase was envisioned with possible peptide elongation.

4.3.1 Cloning Specific Peptide Peptidyl-tRNA into an Expression Vector
The 455 bp full gene sequence for the expression of the specific peptide peptidyltRNA (henceforth referred to as tRNAPhe and pptRNA) was synthesized and cloned into
pET28b expression vector using BglII and BamHI restriction sites. Both the restriction
digested plasmids (pUC57 with the specific peptide peptidyl-tRNA gene and pET28b)
were run on agarose gel as shown in Figure 4.3. The separated restriction digested DNA
was extracted from the gel and the synthesized gene from the pUC57/pptRNA, the small
fragment, was ligated into vector, large fragment from pET28b.
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pUC57/pptRNA

Dbl

pET28b

Dbl

MW

Dbl

Double digested
pET28b

tRNAPhe and
pptRNA gene

Figure 4.3: Cloning of tRNAPhe and pptRNA into pET28b using BglII and BamHI.
Arrows show ligated small and large fragments. MW indicates molecular weight marker
and Dbl indicates plasmid double digested with both BglII and BamHI.

The recombinant plasmid was transformed into JM109 cells and plasmid DNA
from those transformed colonies was extracted and purified. To confirm ligation of the
pptRNA gene in pET28b, the extracted DNA was digested with BglII, BamHI and XbaI
(Figure 4.4). The size of the gene fragments observed matched those expected for the
correct construct. Explicitly, when digested with BglII and BamHI the fragment size
expected is ~450 bp, with BglII and XbaI ~260 bp, and with XbaI and BamHI ~190 bp.
The plasmid was also sequenced for validation of the results.
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MW

455 bp
260 bp
190 bp

Figure 4.4: Diagnostic digests to show ligation of the pptRNA insert in pET28b vector.
Arrows indicate the three fragments of decreasing size.

4.3.2 Expression of tRNAPhe and pptRNA
The pET28b plasmid with the gene insert was transformed into competent PrfB2
cells and grown overnight at 30 °C on LB plates with kanamycin selection. Three
colonies were separately grown in LB at 30 °C and expression was induced with 1 mM
IPTG at OD600 of 0.4, 0.5 and 0.6 respectively. The temperature was immediately
adjusted to 42 °C and cell culture samples were taken after every 15 minutes for one
hour. A Western blot was performed using an anti-Myc antibody to detect the expression
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of pptRNA with the uninduced cells serving as the negative control and c-Myc scytovirin
as positive control. Results indicated no detectable expression of pptRNA.
Transformed PrfB2 cells were then grown in LB at 30 °C and at OD600 of 0.5,
they were induced with 1 mM IPTG. At this time, expression in half the culture was
allowed to proceed at 30 °C while the other half was incubated at 42 °C. Cell culture
samples were collected as before from each culture after every 15 min. The proteins in
these cell samples were separated on a 15 % polyacrylamide gel (Figure 4.5), however,
expression of the peptide was not observed in either case. Lack of pptRNA expression
was confirmed by Western blot.

30 °C
MW

15

30

45

42 °C
60

15

30

45

60

Time (min)

kDa
130
55
35
25
15
10

Figure 4.5: SDS-PAGE to check for expression of pptRNA gene in PrfB2 cells.
Samples collected at 15 min intervals after induction. MW indicates molecular weight
marker. Lanes 3 through 6 were from cultures incubated at 30 °C and lanes 7 through 10
from cultures incubated at 42 °C.
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4.3.3 Small Peptide Gel Optimization
Low pH SDS-PAGE three layer gels have been reported for analysis of aminoacyl
and peptidyl tRNA molecules (Kirchdoerfer et al. 2007). The three layer SDS-PAGE gel
polymerized in the presence of Tris Acetate at pH 5.7 consists of a spacer layer between
the resolving and stacking layers (composition in Appendix A). To better assure
detection of the small peptide, this type of gel was run on the induced pptRNA samples.
However, upon running the cell samples from PrfB2 cells, peptide expression was not
observed using either coomassie or methylene blue staining solutions.
It is known that polyacrylamide gels with higher concentrations and crosslinking
are better suited for resolving low molecular weight proteins. Since the pptRNA peptide
is small, approximately 3 kDa, gels with a higher acrylamide concentration were tested.
Even at a 20% polyacrylamide concentration, the cell samples did not show presence of
the ~3 kDa band (Figure A.1; Appendix A). Also the degree of crosslinking was tested,
changing acrylamide and bisacrylamide concentrations by using 30% T and 2.67% C
solution, wherein T and C represent acrylamide plus bisacrylamide, and bisacrylamide
alone respectively. 12.5% and 16% resolving gels with this degree of crosslinking were
tested (Figures A.2, A.3; Appendix A). Improvement in resolution of bands was not seen
with these gels and no peptide was detected. A final test with 18% resolving gel and 5%
crosslinking was then used for separation and 15.6 kDa protein, PTRHD1 was used as a
test protein for the gel (Figure 4.6). 30% ethylene glycol was also added to the gel and
were run in tris-tricine running buffer to reduce the mobility of small proteins and
peptides. A low molecular weight protein ladder was used to ensure tracking of small

96

peptides during electrophoresis and avoiding loss. Compatibility with Western blot
transfer added to the benefits of utilizing this gel for resolution of small peptides.

MW

1

2

kDa
40
15

4.6
1.7

Figure 4.6: SDS-PAGE; 18% resolving gel with 30% ethylene glycol.
Sample in well 1 consists of PTRHD1 without the His-tag and well 2 is culture sample
for expression of PTRHD1 with His-tag. Arrow indicates PTRHD1 with His-tag.

4.3.4 Expression of pptRNA without elevated tRNAPhe
The combined construct of tRNAPhe with the pptRNA gene did not result in
detectable expression. Formation of a secondary structure due to the tRNA gene will
block the expression of the pptRNA gene. In order to check whether lack of expression
was due to the presence of the tRNAPhe gene, the construct was modified to remove
tRNAPhe. In order to achieve this, the pET28b plasmid with pptRNA insert was
restriction digested with XbaI and BamHI and the small fragment was extracted and
purified. This fragment is 195 bp long containing the ribosome binding site and gene
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sequence for the peptide. This fragment was ligated into pET28b vector that was
digested with these two enzymes. Post-ligation, this plasmid was transformed into
JM109 cells and colonies were selected by kanamycin antibiotic selection. The plasmid
DNA from these colonies was extracted and purified.
To confirm insertion of this fragment, the plasmid DNA from these colonies was
digested with XbaI and XhoI. The DNA was then run on 1% agarose gel. The 235 bp
fragment (distance between BamHI and XhoI in pET28b is 40 bp) observed on the gel
indicates insertion of the pptRNA gene fragment into the plasmid vector. Results of this
diagnostic digest are shown in Figure 4.7.

XbaI+XhoI
1
2
3

MW

XhoI
1
2

3

Figure 4.7: Diagnostic digest to confirm ligation of pptRNA insert without tRNAPhe.
MW indicates molecular weight marker and arrow indicates the 235 bp pptRNA gene
fragment. 1, 2, 3 below the labeled restriction enzymes indicate digested plasmid DNA
from three transformed colonies.
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After confirmation, the plasmid DNA was transformed into PrfB2 cells and
expression of peptidyl tRNA was tested. However, a Western blot still did not show any
expression of the peptide. This plasmid was then transformed into BL21(DE3)pLysS E.
coli cells. The cells were grown in LB at 37 °C and induced at OD600 of 0.5 with 1 mM
IPTG. Samples were collected after every 15 minutes as with the previous expression
experiments. These cell samples were run on 18% polyacrylamide gel containing
ethylene glycol (Figure 4.8).

MW

‒

15

30

45

60

90

120

Time (min)

kDa
40
15
4.6
1.7

Figure 4.8: SDS-PAGE showing expression of pptRNA insert in BL21.
Samples collected every 15 min after induction. ‒ indicates uninduced sample. Arrow
indicates a band of increasing intensity with time.

With a band, under 4.6 kDa in size, increasing in intensity over time, the SDSPAGE gel looked promising for expression of pptRNA gene. Hence, to specifically
confirm expression of the peptide, a Western blot was performed using an anti-His
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antibody (Figure 4.9). Pseudomonas aeruginosa Pth1 (PaPth1) containing an N-terminal
His-tag was used as a positive control for this blot while the uninduced sample was used
as the negative control. However, expression of the pptRNA peptide was not detected in
these cells.

L 1

2

3

L

4

5

6

7

Pth1

Figure 4.9: Western blot for detecting the expression of pptRNA peptide in BL21.
L (Molecular weight marker), 1 (Uninduced sample), 2 (120 min), 3 (PaPth1), 4 (15
min), 5 (45 min), 6 (60 min), 7 (PaPth1)

4.3.5 In Vitro Transcription
With the lack of detectable in vivo expression, in vitro transcription was tested to
make large quantities of tRNAPhe. The tRNAPhe can later be charged with SSIL-Phe
using purified E. coli phenylalanyl tRNA synthetase and further modified to make a
binding partner for Pth1 (Lapidot et al. 1967). RiboMax T7 Express (Promega) was used
for in vitro transcription. Oligonucleotide primers to be used as template for transcription
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were synthesized commercially. The complementary oligonucleotide strands were
annealed to form the template DNA. The template consists of a T7 promoter region and
the tRNAPhe sequence that ends with CCA bases (section 4.2.7). This allows for run-off
transcription on the template. While the sample transcription reaction was set up using
this template, a positive control reaction was set up using the template provided in the kit.
Transcription was allowed to progress for 1 hour after which a DNase was added to
remove the template DNA. The transcribed tRNA was phenol:chloroform extracted and
purified. Production of tRNAPhe was analyzed on an acid urea minigel (Figure 4.10).

Figure 4.10: Acid Urea minigel for detecting the transcription of tRNA.
Positive control reaction along with transcription reaction (left), phenol chloroform
extracted tRNAPhe with bulk peptidyl tRNA and tRNAAla as controls (right). Arrow
indicates the size of tRNAPhe band.
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The positive control transcription reaction generates two fragments of sizes 1.1 kb
and 2.3 kb. However, from the gel results, it was observed that although RNA
transcription occurred in the positive control, the transcribed RNA was too large and
remained in the well. In the transcription reaction, a 76 bp band for the transcribed tRNA
was expected. Assuming the transcription reaction to proceed at an equimolar ratio with
the template DNA provided, intensity of the band was expected to be as that when 20 ng
of tRNA was loaded in the well. Concentration of the pure tRNAAla loaded was very high
and the amount loaded was ~6 μg which is apparent from the very high intensity of the
band on the gel.
Although tRNAPhe band from the transcription reaction appeared smeared and
faint, the appearance of the band at the same size as tRNAAla indicates the successful
transcription of the template, albeit in minor amounts. Smearing of the band could
indicate possible degradation of transcribed tRNA by RNases. Another likely reason for
low transcription yield could be the inefficient annealing of the DNA template causing it
to be a limiting factor for transcription. Addition of a buffer during the annealing process
may assist in strong annealing of the template strands.

4.3.6 EcFRS Expression and Purification
pQE31 plasmid containing the gene sequence for EcFRS, the E. coli tRNAPhe
synthetase, was expressed in XL10 Gold E. coli cells as previously described
(Mermershtain et al. 2011). The cells were grown overnight on LB agar plates with
carbenicillin. These colonies were grown in 250 mL of LB at 37 °C until cell density of
the culture at 600 nm is 0.7. The temperature of the culture was adjusted to 25 °C on ice
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and expression was induced with 0.5 mM IPTG. The cells were harvested after 16 hours
by centrifugation and stored at -80 °C until purification. The cells were lysed and the
protein was purified by immobilized metal affinity chromatography (IMAC) (Figure
4.11). However, the results indicate weak expression levels of the protein and that
background proteins elute along with the imidazole elution step. Despite the background
impurities, the protein can still be used for charging the tRNA as a highly pure enzyme is
not necessary for the charging reaction. Further optimization for increased level of
expression of the protein can be pursued.

MW T

S

P

L FT W 300 mM Imidazole

kDa
130
55
35
25

15

10
Figure 4.11: SDS-PAGE showing purification of EcFRS.
Fractions with EcFRS are highlighted in red. MW (molecular weight marker), T (cell
lysate), S (soluble fraction), P (insoluble fraction), L (loaded fraction), FT (flow through),
W (wash),
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4.4 Conclusion
This work is the first step in solving the high resolution structure of Pth1 in
complex with peptidyl-tRNA. Details of enzyme-substrate interaction are essential for
accurate prediction of compounds inhibiting the enzyme. A homogenous substrate,
production of which is central aim of this part of the research, will help in resolution of
the structure of the complex.
Recombinant expression of the specific peptide peptidyl-tRNA in modified E. coli
cells was pursued so as to make scale up and purification of large quantities of peptidyltRNA straightforward. The gene was placed under the control of a tac promoter to
circumvent the lack of T7 polymerase in PrfB2 cells. However, expression of the peptide
or the peptidyl-tRNA was not observed. This was potentially due to interference of
tRNA gene between the promoter and the ribosome binding site for expression of the
peptide. A secondary structure was presumed to be formed due to the tRNA gene thus
blocking the expression of the pptRNA gene. Hence, the gene fragment consisting of
only the peptide without the tRNAPhe was excised and ligated into another vector for
expression. Overexpression of the peptide was not detected when expression was carried
out in PrfB2 cells at 30 °C. To determine whether the cause for no expression was the tac
promoter, the gene was expressed in BL21 cells under the control of a T7 promoter.
Electrophoretic separation of proteins expressed and Western blot analysis showed lack
of expression. The lack of expression could be attributed to the size of the peptide.
Being as small as 3 kDa, the possibility of degradation by cellular machinery exists.
Although the logical next step was to analyze mRNA expression levels of the gene by a
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northern blot or qRT-PCR, pursuing an alternative strategy for synthesizing the specific
peptide peptidyl-tRNA was a more feasible step.
As an alternative to recombinant production of specific peptide peptidyl-tRNA,
synthetic production of the substrate molecule by in vitro transcription and enzymeassisted charging was examined. Transcription was performed using T7 polymerase and
DNA template consisting of the sequence for tRNAPhe. tRNA production, although at a
lower than desired yield, was confirmed by electrophoresis on an acid-urea mini gel.
Concentration of the tRNAPhe to be obtained after transcription was calculated based on
the amount of template DNA used. In practice, intensity of the band was much lower
than expected in addition to being smeared. Hence, the method for large scale production
needs to be perfected. Post production, the tRNA has to be charged with SSIL-Phe. An
attempt to produce and purify EcFRS required for this reaction resulted in weak
expression level and impurities in the purified protein. Hence, the next step would be to
confirm expression and optimize conditions for increased expression and purification.
Overall, in vitro transcription is a promising alternative to recombinant expression of
peptidyl-tRNA in bacterial cells.
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CHAPTER 5

CONCLUSIONS AND FUTURE WORK

NMR spectroscopic studies of large macromolecular complexes beyond 30 kDa
are aided by selective isotope labeling techniques to overcome the size limitations.
Currently, there is a need for additional economically feasible probes to complement
existing probes. Site specific isotope labeling of aromatic amino acids will be a highly
useful extension to complement the available methyl selective labeling strategy.
Aromatic residues were chosen as targets for SSIL because they have been reported to be
commonly found in protein hotspots, binding and interaction interfaces. The distinct 13C
chemical shifts allow for NMR characterization. An efficient production of SSIL-Phe
and SSIL-Tyr in which 13C has been incorporated at the Cα, Cγ, and Cε positions was
shown in this research. Being inexpensive to produce and having isolated 1H-13C spin
systems, these reagents are widely applicable for probing a variety of large
macromolecular systems. Elimination of carbon-carbon coupling due to 1H-13C labeling
of the side chain epsilon position in phenylalanine and tyrosine thereby eliminates the
need for constant time NMR experiments. This will allow the study of slow tumbling,
larger systems that are difficult to be studied using constant time NMR due to decay of
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NMR signal. This isotopic labeling pattern also significantly simplifies the aromatic
carbon HSQC by reducing the number of 1H-13C resonances per residue to one.
Therefore, unambiguous resonance assignment of phenylalanine and tyrosine in systems
too large for traditional assignment methods is possible by site directed mutagenesis.
Moreover, the difference in 13Cε chemical shift between phenylalanine and tyrosine
allows for better separation in simultaneous site specific labeling of phenylalanine and
tyrosine. Therefore, SSIL-Phe and SSIL-Tyr can be used simultaneously, further
increasing the number of probes in a system. Also reported, is an undemanding method
for high level incorporation of SSIL aromatic amino acids into bacterially expressed
recombinant proteins. Adding to utility, compatibility of the method with ILV-methyl
labeling is also demonstrated. Overall, SSIL reagents (SSIL-Phe and SSIL-Tyr) are
readily accessible and a first step towards inexpensive implementation in systems of
increasing size.
Scope for improving the reagents and increasing their applicability of SSIL-Phe
and SSIL-Tyr is plenty. Implementation in highly deuterated systems is still limited.
However, deuteration of background positions in SSIL Phe or Tyr may be possible. This
will increase the signal to noise ratio while obtaining the useful proton chemical shifts
(i.e. 1H-13C position in SSIL-Phe/Tyr). However, commercial unavailability of 1,3-2H, 213

C-glycerol is limiting this step. Chemical synthesis of 1,3-2H, 2-13C-glycerol from 1,3-

2

H, 2-13C-acetone is now being pursued. Using the synthesized deuterated 2-13C glycerol

as the carbon source recombinant production of background deuterated SSIL reagents can
be achieved. Additionally, the ketoacid precursors of Phe and Tyr have been shown to
efficiently incorporate into recombinant proteins via addition to traditional M9 media.
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Thus, conversion of SSIL Phe ad Tyr amino acids to corresponding ketoacids would be a
significant innovation for more wide spread implementing these new probes. Phe and
Tyr produced by bacterial biosynthesis is one enzymatic step from the corresponding
ketoacid precursor. Thus, it may be possible to inexpensively produce the ketoacid
precursors from the full amino acid, in particular to utilize the previously reported
straightforward media supplementation for high level incorporation (Lichtenecker et al.
2013) which is of particular importance for uniform 13C or 15N labeling or perdeuteration.
Produced in bacteria, alternative isotope labeling of SSIL-Phe/Tyr is readily possible.
Options certainly include the use of different isotopically labeled carbon source (i.e. 113

C-glycerol) to achieve different isotope labeling patterns. Also, the bacterial based

production system for SSIL amino acids was designed to be “modular” making possible
the production of other amino acids, metabolites, natural products, or biomolecules of
interest by replacing the phenylalanine biosynthetic genes with corresponding genes for
production of the compound of interest. Having achieved, efficient production of SSILPhe and SSIL-Tyr, SSIL labeling can now be extended to Trp production in bacteria.
Additional improvements may also be possible in the incorporation of aromatic amino
acids into recombinant proteins, including reducing the amount of SSIL aromatic amino
acids necessary for high level incorporation by engineering bacterial strains (elevating
aromatic uptake via increased transporter/pump expression or biosynthesis knockout
(Miyanoiri et al. 2016)) or extending SSIL incorporation to proteins expressed in Pichia
pastoris.
Having produced SSIL reagents and shown incorporation into recombinant
expressed proteins, a strategy for application of the SSIL regents in the study of the
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enzyme Pth1 in complex with its substrate peptidyl-tRNA was explained. The goal
envisioned was production of SSIL specific peptide peptidyl-tRNA for NMR study of
Pth1 in its bound form. Although the structures of Pth1 from several bacterial species
and a low resolution structure of the enzyme substrate complex are available, a high
resolution structure of Pth1 in a bound state, much less in complex with its natural
substrate peptidyl-tRNA, has not been solved. Given that computational docking to the
apo-structures does not agree with experimental binding, understanding the structure of
the bound state helps in discovering lead compounds that inhibit the enzyme. Further,
high resolution structures of the bound state provide the greatest chance for aiding novel
antibiotic development in terms of directing medicinal chemistry efforts to optimize
small molecule inhibitors.
Obtainment of high resolution structure of Pth1 in complex with peptidyl-tRNA is
limited by the lack of a uniform specific peptide peptidyl-tRNA. This research attempts
to produce milligram quantities of specific peptide peptidyl-tRNA. The specific peptide
peptidyl-tRNA was designed in such a way that it can accommodate incorporation of the
SSIL amino acids with SSIL-Phe at the first position and Ile and Leu residues for methyl
labeling at other positions in the peptide. Since the incorporation method is compatible
for simultaneous labeling of aromatic and methyl residues, site specific labeling of the
peptidyl-tRNA can be achieved. NMR resonance information can then be obtained by
isotope edited NOESY of SSIL peptidyl-tRNA in complex with a 15N labeled Pth1
enzyme. Option also remains open for SSIL incorporation into Pth1 while 15N labeling
the peptidyl-tRNA. Thus, interaction of the peptide region of peptidyl tRNA with the
active site cleft of Pth1 can be fully resolved. Nonetheless, recombinant expression of
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the specific peptide peptidyl tRNA in modified E. coli cells was unsuccessful and an
alternate method for in vitro production of the substrate molecule is now being pursued.
In order to produce specific peptide peptidyl-tRNA, tRNAPhe will be in vitro
transcribed, purified and charged specifically with SSIL-Phe using phenylalanine tRNA
synthetase. A poly amino acid homopolymer will then be polymerized to the charged
tRNAPhe to synthesize the SSIL specific peptide peptidyl-tRNA (Ulkoski et al. 2015).
Availability of both SSIL-Phe and SSIL-Tyr and their distinct chemical shifts at ε
position can be taken advantage of for obtaining complete information about the bound
complex. Fixing the position of SSIL-Phe at the first position (amino acid charged onto
the tRNA), SSIL-Tyr can then be moved along the length of the peptide one residue
position at a time (substrate molecules shown in Figure 5.1). NMR spectroscopic studies
of this synthesized substrate bound to a catalytically inactive mutant of Pth1 will result in
the high resolution study of the complex.
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Figure 5.1: Peptidyl-tRNA substrates with SSIL-Phe (blue) and SSIL-Tyr (pink) to be
synthesized for NMR study.
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APPENDIX A

Small Peptide Gel Optimization Data

Gel Recipes
Three Layer Tris Acetate SDS-PADE Gel
Resolving layer
2 M Tris
20% SDS
Acrylamide/Bis-acrylamide (14.1%T, 3.3% C)
Glycerol
dH2O
pH set to 5.7 with acetic acid
10% ammonium persulfate (APS)
TEMED

3
34.6
2.4
290
258.2

mL
μL
mL
μL
μL

13.7
5

μL
μL

1.5
17.3
600
882.7

mL
μL
μL
μL

7
2.5

μL
μL

1.5
17.3
600
20.53
6

mL
μL
μL
μL
μL

Spacer layer
2 M Tris
20 % SDS
Acryl-Bis (8.6% T, 3.3% C)
dH2O
pH set to 5.7 with acetic acid
10% ammonium persulfate (APS)
TEMED
Stacking layer
2 M Tris
20 % SDS
Acryl-Bis (4.6% T, 3.3% C)
10% ammonium persulfate (APS)
TEMED
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SDS-PAGE with 30 %T and 2.67 % Crosslinking
20% Resolving gel
dH2O
2 M Tris-HCl, pH 8.8
20% SDS
Acrylamide/Bis-acrylamide 30%/0.8%
10% ammonium persulfate (APS)
TEMED

0.377
1.25
31.2
3.33
25
7

mL
mL
μL
mL
μL
μL

1.2
1.25
31.2
2.5
25
7

mL
mL
μL
mL
μL
μL

1.61
1.13
30
3.2
40
14

mL
mL
μL
mL
μL
μL

2.29
1.13
30
2.5
40
14

mL
mL
μL
mL
μL
μL

1.05
1.5
15
0.4
22
5

mL
mL
μL
mL
μL
μL

15 % Resolving gel
dH2O
2 M Tris-HCl, pH 8.8
20% SDS
Acrylamide/Bis-acrylamide 30%/0.8%
10% ammonium persulfate (APS)
TEMED
16 % Resolving gel
dH2O
2 M Tris-HCl, pH 8.8
20% SDS
Acrylamide/Bis-acrylamide 30%/0.8%
10% ammonium persulfate (APS)
TEMED
12.5 % Resolving gel
dH2O
2 M Tris-HCl, pH 8.8
20% SDS
Acrylamide/Bis-acrylamide 30%/0.8%
10% ammonium persulfate (APS)
TEMED
Stacking gel
dH2O
0.5 M Tris-HCl, pH 6.8
20% SDS
Acrylamide/Bis-acrylamide 30%/0.8%
10% ammonium persulfate (APS)
TEMED
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Ethylene glycol gel

Component

5% Stacking gel
(3.3% crosslinking)

18% Resolving gel
(5% crosslinking)

Ethylene glycol

-

2.4 mL

3M Tris-HCl, 0.4% SDS,
pH 8.45

1 mL

2 mL

Acrylamide/bisacrylamide
(40%)

0.5 mL (29:1)

3.6 mL (19:1)

dH2O

2.5 mL

-

10% APS

16 μL

32 μL

TEMED

16 μL

12 μL

Final volume

~4 mL

~8 mL

10X Tris-tricine SDS buffer: 100 mM Tris
100 mM Tricine
0.1% SDS
pH 8.3
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Results
30 °C
MW

15

30

42 °C
15

60

45

30

45

60

Time

35
15
10

Figure A.1: SDS-PAGE using 20% resolving gel with 30% T and 2.67% C.
Expression of pptRNA gene in PrfB2 cells samples collected at 15 min intervals after
induction. MW (molecula r weight marker), Lanes 3,4,5,6 were from cultures incubated
at 30 °C and lanes 7,8,9,10 from cultures incubated at 42 °C.
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kDa
130
55
35
25
15
10

Figure A.2: SDS-PAGE using 12.5% resolving gel with 30% T and 2.67% C.
MW (molecular weight marker), 1 (PTRHD1 without His-tag), 2 (PTRHD1 with His-tag)
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2
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130
55
35
25
15
10

Figure A.3: SDS-PAGE using 16% resolving gel with 30% T and 2.67% C.
MW (molecular weight marker), 1 (PTRHD1 without His-tag), 2 (PTRHD1 with His-tag)
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APPENDIX B

Abundance

GC-MS Supporting Data

Retention time

Figure B.1: GC chromatogram of hydrolyzed Ubiquitin.
Amino acids isolated by cation exchange chromatography were characterized by GC-MS.
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Table B.1: Retention times of amino acids on GC column.
Amino acid

Retention time

Alanine

4.894

Glycine

4.966

Valine

5.318

Leucine

5.446

Serine

6.345

Phenylalanine

6.654

Lysine

7.363

Histidine

7.938

Tyrosine

8.052
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